Foundations · Board-Style Practice
300 practice MCQs

Immunology MCQs

Immunology practice questions: cells of the immune system, innate vs adaptive responses, hypersensitivity reactions, immunodeficiency, autoimmune disease, and the immunologic basis of vaccines and oral infection.

Practice bank

300 Immunology MCQs

Board-style multiple-choice questions with full answers. Switch to Quiz mode to test yourself, or stay in Read mode to study with the answers visible.

  1. 001
    Innate Immune Response Speed
    Why is the innate immune response faster than the adaptive immune response?
    • A.Because it involves the production of specific antibodies
    • B.Because it requires activation by antigen-presenting cells
    • C.Because it involves memory cells that respond quickly
    • D.Because it relies on pre-existing cells and mechanisms that are always active
    Answer: D.Because it relies on pre-existing cells and mechanisms that are always active
  2. 002
    Role of Macrophages in Innate Immunity
    How do macrophages contribute to innate immunity?
    • A.By producing memory cells that respond to future infections
    • B.By phagocytosing pathogens and presenting antigens to adaptive immune cells
    • C.By producing specific antibodies against pathogens
    • D.By secreting cytokines that activate B cells
    Answer: B.By phagocytosing pathogens and presenting antigens to adaptive immune cells
  3. 003
    Antigen Recognition by T-Cells
    How do T-cells in adaptive immunity recognize antigens?
    • A.By recognizing lipids and carbohydrates on pathogens
    • B.By directly binding to pathogens without needing antigen presentation
    • C.By secreting antibodies that neutralize pathogens
    • D.By binding to peptides presented on MHC molecules of antigen-presenting cells
    Answer: D.By binding to peptides presented on MHC molecules of antigen-presenting cells
  4. 004
    Complement System and Innate Immunity
    What is the role of the complement system in innate immunity?
    • A.To activate memory cells in response to infection
    • B.To produce antibodies against pathogens
    • C.To lyse pathogens directly or tag them for destruction by phagocytes
    • D.To present antigens to T cells
    Answer: C.To lyse pathogens directly or tag them for destruction by phagocytes
  5. 005
    Specificity of Adaptive Immunity
    What is a hallmark feature of adaptive immunity compared to innate immunity?
    • A.It has antigen-specific responses, targeting particular pathogens
    • B.It relies on pre-formed antibodies in the bloodstream
    • C.It acts without the need for T or B cells
    • D.It provides a rapid, non-specific response to any pathogen
    Answer: A.It has antigen-specific responses, targeting particular pathogens
  6. 006
    Role of Natural Killer (NK) Cells
    How do natural killer (NK) cells contribute to the innate immune response?
    • A.By directly killing virus-infected cells and tumor cells without prior sensitization
    • B.By activating the adaptive immune response through antigen presentation
    • C.By differentiating into memory cells after an infection
    • D.By producing antibodies against viral antigens
    Answer: A.By directly killing virus-infected cells and tumor cells without prior sensitization
  7. 007
    Helper T Cells and Adaptive Immunity
    What is the primary role of helper T cells (CD4+) in adaptive immunity?
    • A.To activate B cells and cytotoxic T cells through cytokine secretion
    • B.To induce apoptosis in infected cells
    • C.To phagocytose pathogens and debris
    • D.To secrete antibodies against pathogens
    Answer: A.To activate B cells and cytotoxic T cells through cytokine secretion
  8. 008
    Innate Immunity's Role in Inflammation
    How does the innate immune system trigger inflammation in response to infection?
    • A.By activating complement proteins that attack pathogens
    • B.By releasing cytokines and chemokines that recruit immune cells to the infection site
    • C.By promoting the activation of B and T cells
    • D.By activating memory cells to produce cytokines
    Answer: B.By releasing cytokines and chemokines that recruit immune cells to the infection site
  9. 009
    Immunological Memory
    Which component of the immune system is responsible for immunological memory, providing a faster and stronger response upon subsequent exposure to the same pathogen?
    • A.Memory B and T cells
    • B.Natural killer cells
    • C.Neutrophils
    • D.Dendritic cells
    Answer: A.Memory B and T cells
  10. 010
    Pattern Recognition Receptors (PRRs)
    What role do pattern recognition receptors (PRRs) play in the innate immune system?
    • A.They produce specific antibodies against pathogens
    • B.They differentiate between self and non-self antigens on pathogens
    • C.They activate memory T cells to enhance future immune responses
    • D.They recognize conserved molecular patterns on pathogens, initiating an immune response
    Answer: D.They recognize conserved molecular patterns on pathogens, initiating an immune response
  11. 011
    MHC Class I Antigen Processing Pathway
    How are endogenous antigens processed and presented by MHC Class I molecules?
    • A.By being endocytosed and processed in lysosomes
    • B.By binding to MHC Class II molecules on antigen-presenting cells
    • C.By being degraded by the proteasome and presented to CD8+ T cells
    • D.By direct binding to MHC Class I molecules on the cell surface
    Answer: C.By being degraded by the proteasome and presented to CD8+ T cells
  12. 012
    Role of Dendritic Cells in Antigen Presentation
    What is the primary role of dendritic cells in the immune response?
    • A.To inhibit the proliferation of T cells
    • B.To capture antigens, process them, and present them to T cells
    • C.To destroy pathogens through phagocytosis
    • D.To secrete antibodies against specific pathogens
    Answer: B.To capture antigens, process them, and present them to T cells
  13. 013
    MHC Class II and Exogenous Antigens
    Which pathway is responsible for the presentation of exogenous antigens by MHC Class II molecules?
    • A.Antigen processing in the endosomal/lysosomal pathway
    • B.Transfer of antigens to the Golgi apparatus
    • C.Antigen degradation by the proteasome
    • D.Direct presentation of antigens from the cytoplasm
    Answer: A.Antigen processing in the endosomal/lysosomal pathway
  14. 014
    Cross-Presentation by Dendritic Cells
    What is cross-presentation, and why is it important?
    • A.It refers to the transfer of antigens from one cell to another for presentation
    • B.It enables dendritic cells to present exogenous antigens via MHC Class I to CD8+ T cells
    • C.It is the presentation of self-antigens by MHC Class II molecules
    • D.It allows dendritic cells to present antigens to B cells
    Answer: B.It enables dendritic cells to present exogenous antigens via MHC Class I to CD8+ T cells
  15. 015
    Role of TAP Proteins in Antigen Presentation
    What is the function of TAP (Transporter Associated with Antigen Processing) proteins in MHC Class I antigen presentation?
    • A.To degrade peptides into smaller fragments
    • B.To transport peptides from the cytosol into the endoplasmic reticulum for loading onto MHC Class I molecules
    • C.To bind directly to T cell receptors
    • D.To transfer antigens to MHC Class II molecules
    Answer: B.To transport peptides from the cytosol into the endoplasmic reticulum for loading onto MHC Class I molecules
  16. 016
    Invariant Chain and MHC Class II Presentation
    What is the role of the invariant chain in MHC Class II antigen presentation?
    • A.To facilitate the binding of peptides to MHC Class I molecules
    • B.To prevent premature binding of peptides to MHC Class II molecules in the endoplasmic reticulum
    • C.To allow peptides to be processed in the cytoplasm
    • D.To enhance the affinity of MHC Class II for T cell receptors
    Answer: B.To prevent premature binding of peptides to MHC Class II molecules in the endoplasmic reticulum
  17. 017
    Co-Stimulation in T Cell Activation
    What is the role of co-stimulation in T cell activation by dendritic cells?
    • A.It ensures full activation of T cells by providing a second signal in addition to antigen presentation
    • B.It inhibits dendritic cell maturation
    • C.It blocks T cell receptors from binding to MHC molecules
    • D.It is unnecessary for T cell activation
    Answer: A.It ensures full activation of T cells by providing a second signal in addition to antigen presentation
  18. 018
    MHC Polymorphism and Immune Response
    How does the polymorphism of MHC genes affect the immune response?
    • A.It decreases the ability of dendritic cells to present antigens
    • B.It restricts the variety of antigens that can be presented by MHC molecules
    • C.It enhances the diversity of peptides that can be presented to T cells, improving immune recognition
    • D.It increases the likelihood of autoimmune diseases
    Answer: C.It enhances the diversity of peptides that can be presented to T cells, improving immune recognition
  19. 019
    CLIP Peptide in MHC Class II Processing
    What is the function of the CLIP (Class II-associated Invariant Chain Peptide) in the MHC Class II processing pathway?
    • A.To assist in peptide binding to MHC Class I molecules
    • B.To occupy the peptide-binding groove of MHC Class II until appropriate antigens are available
    • C.To degrade antigens for presentation
    • D.To transport MHC Class II molecules to the cell surface
    Answer: B.To occupy the peptide-binding groove of MHC Class II until appropriate antigens are available
  20. 020
    T Cell Receptor Interaction with MHC-Peptide Complex
    What is the primary interaction between a T cell receptor (TCR) and an antigen-presenting cell?
    • A.The TCR directly binds to the invariant chain
    • B.The TCR prevents the activation of other immune cells
    • C.The TCR binds to free antigens in the bloodstream
    • D.The TCR binds to the MHC-peptide complex on the surface of the antigen-presenting cell
    Answer: D.The TCR binds to the MHC-peptide complex on the surface of the antigen-presenting cell
  21. 021
    Activation of B Cells
    What is the primary requirement for the activation of B cells during the immune response?
    • A.Antigen presentation by cytotoxic T cells
    • B.Direct contact with pathogen-associated molecular patterns
    • C.Release of interferons by infected cells
    • D.Binding of antigen to the B cell receptor (BCR) followed by co-stimulation
    Answer: D.Binding of antigen to the B cell receptor (BCR) followed by co-stimulation
  22. 022
    Role of Helper T Cells in B Cell Activation
    How do helper T cells assist in the activation of B cells?
    • A.By releasing histamine to enhance the immune response
    • B.By directly producing antibodies
    • C.By providing co-stimulatory signals through CD40L-CD40 interactions
    • D.By inhibiting the activation of regulatory B cells
    Answer: C.By providing co-stimulatory signals through CD40L-CD40 interactions
  23. 023
    Primary Role of Plasma Cells
    What is the main function of plasma cells in humoral immunity?
    • A.To suppress the immune response during infection
    • B.To present antigens to helper T cells
    • C.To secrete large amounts of antibodies specific to the activating antigen
    • D.To produce memory B cells
    Answer: C.To secrete large amounts of antibodies specific to the activating antigen
  24. 024
    Isotype Switching in B Cells
    What determines the specific class (isotype) of antibodies produced by B cells during an immune response?
    • A.The initial signal provided by antigen-presenting cells
    • B.The type of pathogen that is encountered
    • C.The presence of memory T cells
    • D.Cytokines secreted by helper T cells during B cell activation
    Answer: D.Cytokines secreted by helper T cells during B cell activation
  25. 025
    Memory B Cells and Long-Term Immunity
    How do memory B cells contribute to long-term immunity?
    • A.By preventing the activation of naive B cells
    • B.By rapidly differentiating into plasma cells upon re-exposure to the antigen
    • C.By enhancing the function of cytotoxic T cells
    • D.By constantly secreting low levels of antibodies
    Answer: B.By rapidly differentiating into plasma cells upon re-exposure to the antigen
  26. 026
    Germinal Centers in Lymphoid Tissue
    What is the role of germinal centers in lymphoid tissue during a humoral immune response?
    • A.To facilitate B cell proliferation, somatic hypermutation, and affinity maturation
    • B.To directly secrete antibodies into the bloodstream
    • C.To provide a site for macrophages to engulf antigens
    • D.To trap pathogens and present them to cytotoxic T cells
    Answer: A.To facilitate B cell proliferation, somatic hypermutation, and affinity maturation
  27. 027
    Affinity Maturation and Antibody Specificity
    How does affinity maturation enhance the effectiveness of antibodies?
    • A.By selecting for B cells with higher-affinity receptors for the antigen
    • B.By increasing the number of B cells that recognize self-antigens
    • C.By reducing the diversity of the B cell repertoire
    • D.By altering the antigen structure to make it more recognizable
    Answer: A.By selecting for B cells with higher-affinity receptors for the antigen
  28. 028
    Somatic Hypermutation in B Cells
    What is the significance of somatic hypermutation in B cells during an immune response?
    • A.It enhances the activation of dendritic cells
    • B.It increases the diversity of the antigen-binding region of antibodies
    • C.It promotes the release of cytokines that attract other immune cells
    • D.It leads to the production of antibodies with increased affinity for the antigen
    Answer: D.It leads to the production of antibodies with increased affinity for the antigen
  29. 029
    Mechanism of Neutralization by Antibodies
    How do antibodies neutralize pathogens during an infection?
    • A.By directly lysing the pathogen's cell membrane
    • B.By increasing the activity of cytotoxic T cells
    • C.By enhancing the release of inflammatory cytokines
    • D.By binding to the pathogen and preventing it from interacting with host cells
    Answer: D.By binding to the pathogen and preventing it from interacting with host cells
  30. 030
    Role of IgM in Primary Immune Response
    Why is IgM typically the first antibody produced during a primary immune response?
    • A.Because it can cross the placental barrier
    • B.Because it has the highest affinity for antigens during an initial response
    • C.Because it has a pentameric structure that allows for effective pathogen agglutination
    • D.Because it is secreted by memory B cells
    Answer: C.Because it has a pentameric structure that allows for effective pathogen agglutination
  31. 031
    T Cell Receptor (TCR) Specificity
    What determines the specificity of a T cell receptor (TCR) for its antigen?
    • A.The number of peptide antigens presented to the TCR
    • B.The presence of co-stimulatory molecules on the antigen-presenting cell
    • C.The type of antigen-presenting cell that activates the T cell
    • D.The unique combination of variable regions in the TCR's α and β chains
    Answer: D.The unique combination of variable regions in the TCR's α and β chains
  32. 032
    Role of CD28 in T Cell Activation
    What is the function of CD28 in the activation of T cells?
    • A.It provides a co-stimulatory signal necessary for full T cell activation.
    • B.It inhibits T cell activation to prevent autoimmunity.
    • C.It acts as a co-receptor for antigen recognition.
    • D.It binds directly to the MHC-peptide complex on antigen-presenting cells.
    Answer: A.It provides a co-stimulatory signal necessary for full T cell activation.
  33. 033
    Th1 Cells and Cytokine Production
    Which cytokine is primarily produced by Th1 cells and is critical for cell-mediated immunity?
    • A.Interleukin-4 (IL-4)
    • B.Tumor necrosis factor-alpha (TNF-α)
    • C.Interferon-gamma (IFN-γ)
    • D.Interleukin-10 (IL-10)
    Answer: C.Interferon-gamma (IFN-γ)
  34. 034
    Cytotoxic T Lymphocyte (CTL) Killing Mechanism
    How do cytotoxic T lymphocytes (CTLs) induce apoptosis in infected target cells?
    • A.By inhibiting MHC class I presentation on infected cells
    • B.By phagocytosing infected cells
    • C.By releasing perforin and granzymes to trigger apoptosis
    • D.By producing high levels of cytokines
    Answer: C.By releasing perforin and granzymes to trigger apoptosis
  35. 035
    Antigen Presentation to CD8+ T Cells
    What is required for antigen presentation to CD8+ cytotoxic T cells?
    • A.Direct binding of the pathogen to the T cell receptor
    • B.Peptides bound to MHC class I molecules on the surface of target cells
    • C.Antibodies bound to the surface of the pathogen
    • D.Peptides bound to MHC class II molecules on antigen-presenting cells
    Answer: B.Peptides bound to MHC class I molecules on the surface of target cells
  36. 036
    Regulatory T Cells and Immune Tolerance
    How do regulatory T cells (Tregs) maintain immune tolerance?
    • A.By activating CTLs to eliminate self-reactive T cells
    • B.By blocking co-stimulatory signals to effector T cells
    • C.By enhancing the production of autoantibodies
    • D.By secreting immunosuppressive cytokines like IL-10 and TGF-β
    Answer: D.By secreting immunosuppressive cytokines like IL-10 and TGF-β
  37. 037
    Differentiation of Naive CD4+ T Cells
    Which signal promotes the differentiation of naive CD4+ T cells into Th2 cells?
    • A.Tumor necrosis factor-alpha (TNF-α)
    • B.Interleukin-4 (IL-4)
    • C.Interleukin-12 (IL-12)
    • D.Interferon-gamma (IFN-γ)
    Answer: B.Interleukin-4 (IL-4)
  38. 038
    Role of T Cell Co-Stimulation in Autoimmunity
    Why is the absence of co-stimulatory signals during antigen presentation critical in preventing autoimmunity?
    • A.It enhances T cell receptor binding to self-antigens.
    • B.It increases the production of autoantibodies by B cells.
    • C.It promotes the differentiation of effector T cells.
    • D.It induces anergy in self-reactive T cells, preventing their activation.
    Answer: D.It induces anergy in self-reactive T cells, preventing their activation.
  39. 039
    Th17 Cells and Inflammation
    What is the primary role of Th17 cells in immune responses?
    • A.To inhibit inflammation by secreting IL-10
    • B.To mediate inflammatory responses, particularly against extracellular pathogens
    • C.To enhance cytotoxic T cell responses
    • D.To promote antibody production
    Answer: B.To mediate inflammatory responses, particularly against extracellular pathogens
  40. 040
    Memory T Cell Formation
    How do memory T cells differ from naive T cells?
    • A.Memory T cells require stronger co-stimulatory signals for activation.
    • B.Naive T cells have a shorter lifespan than memory T cells.
    • C.Naive T cells can differentiate into memory B cells.
    • D.Memory T cells respond more rapidly upon re-exposure to their specific antigen.
    Answer: D.Memory T cells respond more rapidly upon re-exposure to their specific antigen.
  41. 041
    Long-Term Immunity in Vaccination
    What is the primary mechanism by which immunological memory provides long-term protection after vaccination?
    • A.By maintaining a pool of memory B and T cells that can rapidly respond upon re-exposure to the antigen
    • B.By preventing the entry of pathogens into the host
    • C.By inducing inflammation in the absence of infection
    • D.By constantly producing antibodies in the absence of antigen
    Answer: A.By maintaining a pool of memory B and T cells that can rapidly respond upon re-exposure to the antigen
  42. 042
    Memory B Cells and Their Function
    What is the key role of memory B cells in immune responses after vaccination?
    • A.To promote the destruction of infected cells
    • B.To produce antibodies more rapidly and in larger quantities upon re-exposure to the antigen
    • C.To secrete cytokines that enhance T cell activity
    • D.To act as antigen-presenting cells to naive T cells
    Answer: B.To produce antibodies more rapidly and in larger quantities upon re-exposure to the antigen
  43. 043
    Primary vs. Secondary Immune Response
    What is a major difference between the primary immune response and the secondary immune response after vaccination?
    • A.The secondary immune response is faster and more robust due to the presence of memory cells
    • B.The primary response requires booster doses to be effective
    • C.The primary response involves only T cells, while the secondary response involves both B and T cells
    • D.The secondary response always leads to the elimination of the pathogen, while the primary response does not
    Answer: A.The secondary immune response is faster and more robust due to the presence of memory cells
  44. 044
    Role of Central Memory T Cells
    How do central memory T cells differ from effector memory T cells in their role in immune memory?
    • A.They produce antibodies upon re-exposure to the antigen
    • B.They reside in secondary lymphoid organs and can proliferate upon reactivation
    • C.They remain in peripheral tissues and are ready for immediate action
    • D.They regulate the immune response by suppressing other immune cells
    Answer: B.They reside in secondary lymphoid organs and can proliferate upon reactivation
  45. 045
    Activation of Memory T Cells
    What is required for the activation of memory T cells during a secondary immune response?
    • A.Recognition of the specific antigen they encountered during the initial response
    • B.Activation by regulatory T cells (Tregs)
    • C.Interaction with plasma cells in lymphoid tissues
    • D.Constant exposure to the antigen following vaccination
    Answer: A.Recognition of the specific antigen they encountered during the initial response
  46. 046
    Longevity of Immunological Memory
    Which factor primarily determines the longevity of immunological memory after vaccination?
    • A.The strength of the innate immune response
    • B.The survival of memory B and T cells over time
    • C.The number of initial antigen exposures
    • D.The degree of inflammation generated during vaccination
    Answer: B.The survival of memory B and T cells over time
  47. 047
    Memory T Cells in Mucosal Immunity
    Why are memory T cells important for mucosal immunity in the context of vaccination?
    • A.They stimulate long-term inflammation to protect mucosal surfaces
    • B.They enhance antigen presentation by dendritic cells in mucosal tissues
    • C.They produce antibodies that are secreted into mucosal tissues
    • D.They provide rapid immune responses at mucosal surfaces, preventing pathogen entry
    Answer: D.They provide rapid immune responses at mucosal surfaces, preventing pathogen entry
  48. 048
    Clonal Expansion in Immunological Memory
    What happens during the clonal expansion of memory cells following re-exposure to an antigen?
    • A.Memory cells undergo apoptosis to limit immune activation
    • B.Memory cells present antigens to other immune cells
    • C.Memory cells rapidly proliferate, increasing the number of antigen-specific cells to combat the infection
    • D.Memory cells differentiate into innate immune cells
    Answer: C.Memory cells rapidly proliferate, increasing the number of antigen-specific cells to combat the infection
  49. 049
    Impact of Antigenic Variation on Immunological Memory
    How does antigenic variation in pathogens affect the effectiveness of immunological memory from vaccination?
    • A.It enhances memory cell production against the variant
    • B.It may allow the pathogen to evade immune recognition, reducing vaccine effectiveness
    • C.It reduces the need for booster vaccinations
    • D.It increases the strength of the immune response
    Answer: B.It may allow the pathogen to evade immune recognition, reducing vaccine effectiveness
  50. 050
    Role of Memory Plasma Cells
    What is the primary function of memory plasma cells in long-term immunity?
    • A.To stimulate naive B cells to differentiate
    • B.To produce cytokines that activate T cells
    • C.To continuously produce antibodies specific to the original antigen
    • D.To act as antigen-presenting cells
    Answer: C.To continuously produce antibodies specific to the original antigen
  51. 051
    Class Switching in Immunoglobulins
    What is the primary significance of class switching in immunoglobulins?
    • A.It alters the antigen specificity of the antibody
    • B.It changes the affinity of the antibody for its antigen
    • C.It enhances the neutralizing ability of IgM
    • D.It allows the immune response to adapt by producing different isotypes without changing antigen specificity
    Answer: D.It allows the immune response to adapt by producing different isotypes without changing antigen specificity
  52. 052
    Function of IgE in Allergic Reactions
    Which of the following describes the primary role of IgE in allergic reactions?
    • A.Activating the complement system directly
    • B.Opsonizing pathogens for phagocytosis
    • C.Binding to mast cells and basophils, triggering histamine release upon antigen exposure
    • D.Neutralizing bacterial toxins
    Answer: C.Binding to mast cells and basophils, triggering histamine release upon antigen exposure
  53. 053
    First Antibody Produced in Response to Infection
    Which immunoglobulin class is typically the first to be produced during a primary immune response?
    • A.IgG
    • B.IgA
    • C.IgE
    • D.IgM
    Answer: D.IgM
  54. 054
    Role of the J Chain in Immunoglobulins
    What is the primary role of the J chain in immunoglobulins?
    • A.It enhances antigen binding to IgG molecules
    • B.It binds IgE to mast cells
    • C.It links monomers of IgA and IgM to form dimers or pentamers
    • D.It facilitates antigen presentation to T cells
    Answer: C.It links monomers of IgA and IgM to form dimers or pentamers
  55. 055
    Mucosal Immunity and IgA
    What is the primary function of IgA in mucosal immunity?
    • A.Neutralizing pathogens at mucosal surfaces
    • B.Triggering histamine release during allergic reactions
    • C.Activating the classical complement pathway
    • D.Facilitating phagocytosis by macrophages
    Answer: A.Neutralizing pathogens at mucosal surfaces
  56. 056
    IgG and Placental Transfer
    Why is IgG unique among immunoglobulins in its ability to cross the placenta?
    • A.It interacts with Fc receptors that mediate transport across the placental barrier
    • B.It binds to a receptor on placental cells that allows it to transfer from maternal to fetal circulation
    • C.It has a higher affinity for antigens than other immunoglobulins
    • D.It is the smallest immunoglobulin and can pass through pores in the placenta
    Answer: A.It interacts with Fc receptors that mediate transport across the placental barrier
  57. 057
    Opsonization and Immunoglobulins
    Which immunoglobulin class is most effective at opsonization?
    • A.IgM
    • B.IgE
    • C.IgA
    • D.IgG
    Answer: D.IgG
  58. 058
    Complement Activation by IgM
    Why is IgM particularly effective at activating the complement system?
    • A.It has a high affinity for antigens and binds them tightly
    • B.It neutralizes viruses before they can infect cells
    • C.It binds to mast cells and releases inflammatory mediators
    • D.It forms pentamers, allowing for efficient binding to C1q, the first component of the classical complement pathway
    Answer: D.It forms pentamers, allowing for efficient binding to C1q, the first component of the classical complement pathway
  59. 059
    Function of IgD in the Immune Response
    What is the primary function of IgD in the immune system?
    • A.Binding to basophils and initiating allergic responses
    • B.Acting as a receptor on the surface of B cells to initiate activation
    • C.Cross-linking with antigens to trigger the complement cascade
    • D.Neutralizing pathogens in the bloodstream
    Answer: B.Acting as a receptor on the surface of B cells to initiate activation
  60. 060
    Affinity Maturation in Immunoglobulins
    What process allows for increased affinity of antibodies during the immune response?
    • A.Class switching to different isotypes
    • B.Increased binding of IgE to mast cells
    • C.Somatic hypermutation in the variable regions of the antibody genes
    • D.Production of additional light chain variants
    Answer: C.Somatic hypermutation in the variable regions of the antibody genes
  61. 061
    Classical Pathway Activation
    Which of the following primarily activates the classical pathway of the complement system?
    • A.Release of cytokines during inflammation
    • B.Direct binding of microbial surfaces to complement proteins
    • C.Bacterial endotoxins
    • D.Antigen-antibody complexes binding to C1
    Answer: D.Antigen-antibody complexes binding to C1
  62. 062
    Role of C3 Convertase in the Complement System
    What is the main function of C3 convertase in the complement cascade?
    • A.To bind directly to pathogens for opsonization
    • B.To promote blood clotting during inflammation
    • C.To cleave C3 into C3a and C3b, amplifying the complement response
    • D.To recruit macrophages to the site of infection
    Answer: C.To cleave C3 into C3a and C3b, amplifying the complement response
  63. 063
    Lectin Pathway Activation
    How is the lectin pathway of complement activation initiated?
    • A.By the spontaneous activation of C3 in the blood
    • B.By the presence of antigen-antibody complexes
    • C.By mannose-binding lectin binding to carbohydrates on microbial surfaces
    • D.By direct interaction with natural killer cells
    Answer: C.By mannose-binding lectin binding to carbohydrates on microbial surfaces
  64. 064
    Terminal Complement Complex (MAC) Function
    What is the primary role of the membrane attack complex (MAC) in the complement system?
    • A.To enhance phagocytosis by immune cells
    • B.To form pores in the cell membranes of pathogens, leading to lysis
    • C.To initiate an inflammatory response
    • D.To neutralize viruses through binding
    Answer: B.To form pores in the cell membranes of pathogens, leading to lysis
  65. 065
    Role of C5a in Inflammation
    How does the complement protein C5a contribute to the immune response?
    • A.By acting as a potent chemoattractant for neutrophils
    • B.By inhibiting T-cell activation
    • C.By directly opsonizing pathogens
    • D.By lysing bacterial cell walls
    Answer: A.By acting as a potent chemoattractant for neutrophils
  66. 066
    Regulation of Complement Activity by Factor I
    What is the role of complement regulatory protein Factor I?
    • A.To promote the activation of the alternative pathway
    • B.To inactivate C3b and C4b, preventing excessive complement activation
    • C.To stabilize the C3 convertase on microbial surfaces
    • D.To recruit T cells to the site of infection
    Answer: B.To inactivate C3b and C4b, preventing excessive complement activation
  67. 067
    Alternative Pathway of Complement Activation
    What is the unique feature of the alternative pathway of complement activation compared to the classical pathway?
    • A.It involves the release of cytokines before complement activation
    • B.It activates natural killer cells directly
    • C.It requires antibodies to initiate the response
    • D.It is activated spontaneously on microbial surfaces without the need for antibodies
    Answer: D.It is activated spontaneously on microbial surfaces without the need for antibodies
  68. 068
    Anaphylatoxins and Their Role in Immune Response
    Which complement components are classified as anaphylatoxins and what is their function?
    • A.C6 and C7; they lyse pathogens
    • B.C3b and C5b; they promote opsonization
    • C.C1 and C2; they activate T cells
    • D.C3a, C4a, and C5a; they enhance inflammation by inducing smooth muscle contraction and increasing vascular permeability
    Answer: D.C3a, C4a, and C5a; they enhance inflammation by inducing smooth muscle contraction and increasing vascular permeability
  69. 069
    Deficiency in C1 Inhibitor and Disease
    Which condition is associated with a deficiency in C1 inhibitor (C1-INH) in the complement system?
    • A.Hereditary angioedema
    • B.Systemic lupus erythematosus
    • C.Rheumatoid arthritis
    • D.Chronic granulomatous disease
    Answer: A.Hereditary angioedema
  70. 070
    Opsonization and the Complement System
    Which complement component is primarily responsible for opsonization of pathogens, facilitating their clearance by phagocytes?
    • A.C5a
    • B.C1q
    • C.C3b
    • D.C9
    Answer: C.C3b
  71. 071
    Central Tolerance in the Thymus
    How does central tolerance eliminate self-reactive T cells in the thymus?
    • A.By promoting the differentiation of T cells into regulatory T cells
    • B.By inducing apoptosis of T cells that strongly bind self-antigens during negative selection
    • C.By inducing somatic hypermutation in T cell receptors
    • D.By enhancing the expression of non-self antigens in the thymus
    Answer: B.By inducing apoptosis of T cells that strongly bind self-antigens during negative selection
  72. 072
    Anergy in Peripheral Tolerance
    What is the primary outcome when a self-reactive T cell encounters an antigen without costimulation in the periphery?
    • A.It migrates to secondary lymphoid tissues and activates B cells
    • B.It undergoes clonal expansion and differentiates into an effector T cell
    • C.It differentiates into a cytotoxic T cell
    • D.It becomes anergic, losing its ability to respond to antigen
    Answer: D.It becomes anergic, losing its ability to respond to antigen
  73. 073
    Role of Regulatory T Cells (Tregs)
    What is the main function of regulatory T cells (Tregs) in maintaining self-tolerance?
    • A.To activate B cells to produce autoantibodies
    • B.To suppress immune responses against self-antigens and prevent autoimmunity
    • C.To promote the differentiation of naïve T cells into effector cells
    • D.To enhance the function of cytotoxic T cells
    Answer: B.To suppress immune responses against self-antigens and prevent autoimmunity
  74. 074
    Mechanism of Peripheral Tolerance in B Cells
    How is peripheral tolerance achieved in B cells that recognize self-antigens in the absence of T cell help?
    • A.By enhancing the presentation of antigens to helper T cells
    • B.By inducing B cell anergy or apoptosis
    • C.By promoting somatic hypermutation in the B cell receptor
    • D.By activating the complement system
    Answer: B.By inducing B cell anergy or apoptosis
  75. 075
    Function of Clonal Deletion in Tolerance
    What is the purpose of clonal deletion in the development of immune tolerance?
    • A.To enhance the proliferation of immune cells
    • B.To activate memory T cells against self-antigens
    • C.To inhibit the function of antigen-presenting cells
    • D.To eliminate self-reactive lymphocytes during their development
    Answer: D.To eliminate self-reactive lymphocytes during their development
  76. 076
    Role of AIRE in Central Tolerance
    How does the Autoimmune Regulator (AIRE) gene contribute to central tolerance in the thymus?
    • A.By inhibiting the expression of tissue-specific antigens
    • B.By promoting the expression of tissue-specific antigens in the thymus for negative selection
    • C.By promoting the migration of T cells to the periphery
    • D.By enhancing the selection of autoreactive T cells
    Answer: B.By promoting the expression of tissue-specific antigens in the thymus for negative selection
  77. 077
    Molecular Mimicry and Autoimmunity
    How does molecular mimicry contribute to the development of autoimmunity?
    • A.It involves the suppression of regulatory T cell function
    • B.It allows immune cells to recognize both self and foreign antigens
    • C.It occurs when foreign antigens resemble self-antigens, leading to an immune response against self
    • D.It enhances immune tolerance by suppressing T cell activation
    Answer: C.It occurs when foreign antigens resemble self-antigens, leading to an immune response against self
  78. 078
    Role of Fas-FasL in Immune Homeostasis
    What is the role of the Fas-FasL pathway in maintaining immune homeostasis?
    • A.To promote the activation of T cells in response to self-antigens
    • B.To induce somatic hypermutation in B cells
    • C.To enhance the production of antibodies by plasma cells
    • D.To trigger apoptosis in activated lymphocytes, preventing autoimmune responses
    Answer: D.To trigger apoptosis in activated lymphocytes, preventing autoimmune responses
  79. 079
    Mechanism of Autoimmune Lymphoproliferative Syndrome (ALPS)
    What causes Autoimmune Lymphoproliferative Syndrome (ALPS)?
    • A.Excessive activation of regulatory T cells
    • B.Overexpression of tissue-specific antigens in the thymus
    • C.Defective Fas-mediated apoptosis of self-reactive lymphocytes
    • D.Enhanced thymic selection of autoreactive T cells
    Answer: C.Defective Fas-mediated apoptosis of self-reactive lymphocytes
  80. 080
    Tolerogenic Dendritic Cells in Peripheral Tolerance
    How do tolerogenic dendritic cells contribute to peripheral tolerance?
    • A.By enhancing the proliferation of autoreactive T cells
    • B.By promoting the activation of cytotoxic T cells against self-antigens
    • C.By stimulating the production of pro-inflammatory cytokines
    • D.By presenting self-antigens to T cells without costimulation, leading to anergy or deletion
    Answer: D.By presenting self-antigens to T cells without costimulation, leading to anergy or deletion
  81. 081
    Mechanism of Type I Hypersensitivity
    What is the primary mechanism that triggers a Type I hypersensitivity reaction?
    • A.Cross-linking of IgE antibodies on mast cells and basophils, leading to degranulation
    • B.Activation of cytotoxic T cells
    • C.Activation of complement proteins
    • D.Formation of immune complexes between antigen and antibody
    Answer: A.Cross-linking of IgE antibodies on mast cells and basophils, leading to degranulation
  82. 082
    Type II Hypersensitivity and Tissue Damage
    In a Type II hypersensitivity reaction, how is tissue damage primarily mediated?
    • A.By IgE-mediated histamine release
    • B.By T cell-mediated cytotoxicity
    • C.By IgG and IgM antibodies binding to cell surface antigens, leading to complement activation or phagocytosis
    • D.By immune complexes depositing in tissues
    Answer: C.By IgG and IgM antibodies binding to cell surface antigens, leading to complement activation or phagocytosis
  83. 083
    Type III Hypersensitivity Mechanism
    What causes tissue damage in Type III hypersensitivity reactions?
    • A.Direct lysis of target cells by antibodies
    • B.Activation of CD8+ T cells
    • C.Deposition of antigen-antibody complexes in tissues, leading to inflammation
    • D.Degranulation of mast cells
    Answer: C.Deposition of antigen-antibody complexes in tissues, leading to inflammation
  84. 084
    Type IV Hypersensitivity Timeline
    What is characteristic of the delayed onset of a Type IV hypersensitivity reaction?
    • A.Antibody-mediated cytotoxicity
    • B.Immediate release of histamine
    • C.A cell-mediated immune response typically occurring 48-72 hours after antigen exposure
    • D.Formation of immune complexes
    Answer: C.A cell-mediated immune response typically occurring 48-72 hours after antigen exposure
  85. 085
    Allergic Rhinitis and Hypersensitivity
    Allergic rhinitis is primarily associated with which type of hypersensitivity reaction?
    • A.Type IV
    • B.Type I
    • C.Type III
    • D.Type II
    Answer: B.Type I
  86. 086
    Hemolytic Disease of the Newborn
    Hemolytic disease of the newborn (HDN) is an example of which type of hypersensitivity?
    • A.Type IV
    • B.Type I
    • C.Type II
    • D.Type III
    Answer: C.Type II
  87. 087
    Role of T cells in Type IV Hypersensitivity
    In Type IV hypersensitivity reactions, which cell type plays the primary role in mediating the immune response?
    • A.T cells, particularly CD4+ and CD8+ T cells
    • B.Mast cells
    • C.B cells
    • D.Neutrophils
    Answer: A.T cells, particularly CD4+ and CD8+ T cells
  88. 088
    Serum Sickness and Hypersensitivity
    Which hypersensitivity reaction is associated with serum sickness?
    • A.Type III
    • B.Type II
    • C.Type IV
    • D.Type I
    Answer: A.Type III
  89. 089
    Tuberculin Skin Test and Hypersensitivity
    The tuberculin skin test used to diagnose tuberculosis is an example of which type of hypersensitivity reaction?
    • A.Type III
    • B.Type IV
    • C.Type I
    • D.Type II
    Answer: B.Type IV
  90. 090
    Anaphylaxis and Hypersensitivity
    Anaphylaxis is a severe systemic manifestation of which hypersensitivity reaction?
    • A.Type II
    • B.Type I
    • C.Type III
    • D.Type IV
    Answer: B.Type I
  91. 091
    Cytokine Signaling Pathways
    Which of the following is a major signaling pathway activated by cytokine receptors that leads to gene transcription?
    • A.cAMP signaling pathway
    • B.JAK-STAT pathway
    • C.NF-kB pathway
    • D.MAPK pathway
    Answer: B.JAK-STAT pathway
  92. 092
    Role of IL-2 in Immune Regulation
    What is the primary function of interleukin-2 (IL-2) in immune regulation?
    • A.To suppress immune responses and promote tolerance
    • B.To stimulate the proliferation of T cells during an immune response
    • C.To enhance the production of antibodies by B cells
    • D.To inhibit the activation of macrophages
    Answer: B.To stimulate the proliferation of T cells during an immune response
  93. 093
    Tumor Necrosis Factor-alpha (TNF-α)
    How does TNF-α contribute to the immune response during infection?
    • A.By reducing the proliferation of T cells
    • B.By promoting inflammation and inducing apoptosis of infected cells
    • C.By increasing the activation of B cells and antibody production
    • D.By enhancing the phagocytosis of antigens by neutrophils
    Answer: B.By promoting inflammation and inducing apoptosis of infected cells
  94. 094
    Chemokine Receptor CCR5 and HIV
    How does the CCR5 chemokine receptor play a role in HIV infection?
    • A.It acts as a coreceptor, allowing HIV to enter and infect T cells
    • B.It induces cytokine production to block viral replication
    • C.It inhibits HIV from entering host cells
    • D.It helps the immune system neutralize the virus
    Answer: A.It acts as a coreceptor, allowing HIV to enter and infect T cells
  95. 095
    Interferon-gamma (IFN-γ) Function
    What is the primary role of interferon-gamma (IFN-γ) in immune regulation?
    • A.To increase the activation of B cells and antibody production
    • B.To suppress immune responses during chronic inflammation
    • C.To activate macrophages and enhance their pathogen-killing abilities
    • D.To inhibit viral replication in host cells
    Answer: C.To activate macrophages and enhance their pathogen-killing abilities
  96. 096
    Role of Transforming Growth Factor-beta (TGF-β)
    What is the primary immunosuppressive function of TGF-β in the immune system?
    • A.To promote the production of pro-inflammatory cytokines
    • B.To inhibit the activation and proliferation of T cells
    • C.To activate cytotoxic T lymphocytes (CTLs)
    • D.To enhance the production of chemokines
    Answer: B.To inhibit the activation and proliferation of T cells
  97. 097
    Chemokine CXCL8 (IL-8) in Immune Response
    What is the role of CXCL8 (IL-8) in immune responses?
    • A.To stimulate B cell differentiation
    • B.To induce apoptosis in virally infected cells
    • C.To inhibit the activity of regulatory T cells
    • D.To recruit neutrophils to sites of infection or inflammation
    Answer: D.To recruit neutrophils to sites of infection or inflammation
  98. 098
    IL-10 and Anti-Inflammatory Effects
    What is the primary role of interleukin-10 (IL-10) in the immune system?
    • A.To promote antibody production by B cells
    • B.To stimulate the proliferation of T cells and NK cells
    • C.To suppress inflammatory responses and inhibit the activation of macrophages and dendritic cells
    • D.To enhance cytokine production in pro-inflammatory pathways
    Answer: C.To suppress inflammatory responses and inhibit the activation of macrophages and dendritic cells
  99. 099
    Role of Chemokines in Lymphocyte Trafficking
    How do chemokines contribute to lymphocyte trafficking during an immune response?
    • A.By guiding lymphocytes to specific tissues or sites of infection based on chemokine gradients
    • B.By reducing the movement of T cells into inflamed tissues
    • C.By suppressing T cell activation
    • D.By enhancing cytokine production in target tissues
    Answer: A.By guiding lymphocytes to specific tissues or sites of infection based on chemokine gradients
  100. 100
    IL-1 and Fever Induction
    What is the role of IL-1 in the systemic immune response to infection?
    • A.It inhibits the release of chemokines from immune cells
    • B.It induces fever by acting on the hypothalamus
    • C.It suppresses the production of T cells
    • D.It enhances the activation of natural killer (NK) cells
    Answer: B.It induces fever by acting on the hypothalamus
  101. 101
    Defining Feature of Primary Immunodeficiency
    What is the defining characteristic of primary immunodeficiency disorders?
    • A.They are genetically inherited and present early in life
    • B.They are always associated with autoimmune diseases
    • C.They are caused by environmental factors such as infections or chemotherapy
    • D.They are temporary and resolve without treatment
    Answer: A.They are genetically inherited and present early in life
  102. 102
    Cause of Secondary Immunodeficiencies
    Which of the following is a common cause of secondary immunodeficiency disorders?
    • A.Overproduction of immunoglobulins
    • B.Inherited mutations in immune system genes
    • C.Increased levels of T-cell activation
    • D.Acquired factors such as HIV infection or malnutrition
    Answer: D.Acquired factors such as HIV infection or malnutrition
  103. 103
    Common Presentation of Severe Combined Immunodeficiency (SCID)
    How does severe combined immunodeficiency (SCID) typically present in infants?
    • A.Overactive immune responses to common antigens
    • B.Mild infections that resolve without intervention
    • C.Chronic inflammation in the absence of infections
    • D.Recurrent, severe infections beginning in early infancy
    Answer: D.Recurrent, severe infections beginning in early infancy
  104. 104
    AIDS as a Secondary Immunodeficiency
    Why is AIDS considered a secondary immunodeficiency disorder?
    • A.It results from the acquired infection with HIV, which destroys immune cells
    • B.It primarily affects only B cells
    • C.It is present at birth and causes severe infections
    • D.It is caused by an inherited genetic mutation
    Answer: A.It results from the acquired infection with HIV, which destroys immune cells
  105. 105
    Deficiency of B Cells in Primary Immunodeficiency
    In B cell-related primary immunodeficiencies, such as X-linked agammaglobulinemia, what is the primary defect?
    • A.Failure to produce functional antibodies due to a lack of mature B cells
    • B.Excessive proliferation of B cells
    • C.Overproduction of antibodies leading to autoimmunity
    • D.Impaired T-cell signaling to B cells
    Answer: A.Failure to produce functional antibodies due to a lack of mature B cells
  106. 106
    Treatment for Primary Immunodeficiency
    What is the most common treatment approach for patients with primary immunodeficiencies?
    • A.Antiviral medications
    • B.Chemotherapy
    • C.Immunoglobulin replacement therapy and bone marrow transplantation
    • D.Broad-spectrum antibiotics
    Answer: C.Immunoglobulin replacement therapy and bone marrow transplantation
  107. 107
    Common Secondary Immunodeficiency Causes
    Which of the following conditions is a leading cause of secondary immunodeficiency?
    • A.Immunosuppressive treatments, such as chemotherapy or corticosteroids
    • B.Genetic mutations in T cell receptors
    • C.Excessive production of cytokines in the immune system
    • D.Inherited deficiencies in complement proteins
    Answer: A.Immunosuppressive treatments, such as chemotherapy or corticosteroids
  108. 108
    Diagnosis of Immunodeficiency Disorders
    What diagnostic test is typically used to evaluate immunodeficiency disorders?
    • A.Flow cytometry to assess lymphocyte populations and function
    • B.Complete blood count (CBC) to measure red blood cells
    • C.Genetic testing for known mutations
    • D.Serum protein electrophoresis
    Answer: A.Flow cytometry to assess lymphocyte populations and function
  109. 109
    Opportunistic Infections in Immunodeficiency
    Why are individuals with immunodeficiency disorders more susceptible to opportunistic infections?
    • A.Their immune systems produce too many antibodies
    • B.Their weakened immune systems cannot control normally harmless organisms
    • C.Their immune systems are overactive, leading to constant inflammation
    • D.Their neutrophils are hyperactive, causing tissue damage
    Answer: B.Their weakened immune systems cannot control normally harmless organisms
  110. 110
    Gene Therapy in Immunodeficiency Treatment
    What is the role of gene therapy in the treatment of certain primary immunodeficiencies, such as SCID?
    • A.To correct the genetic defect causing the disorder
    • B.To stimulate the immune system to overproduce antibodies
    • C.To prevent infections through vaccination
    • D.To suppress the immune response to prevent autoimmunity
    Answer: A.To correct the genetic defect causing the disorder
  111. 111
    Mechanism of Subunit Vaccines
    How do subunit vaccines provide immunity against specific pathogens?
    • A.By presenting isolated antigens of the pathogen to stimulate an immune response without causing disease
    • B.By using viral vectors to deliver the pathogen’s genetic material
    • C.By introducing inactivated whole pathogens to stimulate a full immune response
    • D.By using live, attenuated forms of the pathogen to induce both humoral and cell-mediated immunity
    Answer: A.By presenting isolated antigens of the pathogen to stimulate an immune response without causing disease
  112. 112
    Vaccine Adjuvants
    What is the main purpose of adding an adjuvant to a vaccine formulation?
    • A.To decrease the production costs of the vaccine
    • B.To inactivate the antigen and make it safer for administration
    • C.To eliminate the need for booster shots
    • D.To enhance the immune system's response to the vaccine antigen
    Answer: D.To enhance the immune system's response to the vaccine antigen
  113. 113
    Principle of Live Attenuated Vaccines
    What is the primary mechanism by which live attenuated vaccines generate immunity?
    • A.By inhibiting the pathogen’s entry into host cells
    • B.By preventing the replication of the pathogen in the host
    • C.By mimicking a natural infection and inducing both humoral and cellular immunity
    • D.By inducing the production of memory B cells only
    Answer: C.By mimicking a natural infection and inducing both humoral and cellular immunity
  114. 114
    Limitations of Inactivated Vaccines
    What is a significant limitation of inactivated vaccines compared to live attenuated vaccines?
    • A.They usually require multiple doses or booster shots to maintain immunity
    • B.They typically stimulate stronger cellular immune responses
    • C.They can cause disease in immunocompromised individuals
    • D.They provide lifelong immunity with one dose
    Answer: A.They usually require multiple doses or booster shots to maintain immunity
  115. 115
    Mechanism of DNA Vaccines
    How do DNA vaccines stimulate the immune system?
    • A.By incorporating recombinant proteins into the immune system
    • B.By using inactivated viruses to trigger antibody production
    • C.By delivering genetic material that encodes for pathogen antigens, leading to their expression and subsequent immune response
    • D.By using live, attenuated bacteria to induce an immune response
    Answer: C.By delivering genetic material that encodes for pathogen antigens, leading to their expression and subsequent immune response
  116. 116
    Immunological Basis for Conjugate Vaccines
    Why are conjugate vaccines particularly effective in infants and young children?
    • A.They contain live, weakened forms of the pathogen
    • B.They do not require memory cell formation to be effective
    • C.They link polysaccharides to proteins, enhancing the immune system’s ability to recognize the antigen
    • D.They can elicit a strong immune response without the need for adjuvants
    Answer: C.They link polysaccharides to proteins, enhancing the immune system’s ability to recognize the antigen
  117. 117
    Role of B Cells in Vaccine Response
    Which process involves B cells in the immune response to vaccination?
    • A.Production of antibodies specific to the vaccine antigen
    • B.Secretion of cytokines to stimulate other immune cells
    • C.Activation of the complement system
    • D.Direct attack on infected host cells
    Answer: A.Production of antibodies specific to the vaccine antigen
  118. 118
    Immune Memory Induced by Vaccines
    What is the primary role of memory cells in vaccine-induced immunity?
    • A.To generate an immediate immune response upon vaccination
    • B.To provide long-lasting immunity by responding quickly upon subsequent exposure to the pathogen
    • C.To prevent the spread of the pathogen within the host
    • D.To eliminate residual antigens from the vaccination
    Answer: B.To provide long-lasting immunity by responding quickly upon subsequent exposure to the pathogen
  119. 119
    Challenge with Developing Vaccines for RNA Viruses
    What is a primary challenge in developing effective vaccines for RNA viruses, such as influenza or HIV?
    • A.The lack of suitable adjuvants for RNA vaccines
    • B.The high mutation rate of RNA viruses, leading to antigenic variation
    • C.The inability of RNA viruses to replicate in host cells
    • D.The low mutation rate of RNA viruses
    Answer: B.The high mutation rate of RNA viruses, leading to antigenic variation
  120. 120
    Mechanism of Recombinant Vector Vaccines
    How do recombinant vector vaccines work to elicit an immune response?
    • A.By stimulating antibody production without introducing the pathogen into the host
    • B.By providing live attenuated viruses that directly replicate in host cells
    • C.By incorporating whole pathogens into the vaccine to stimulate immunity
    • D.By using a harmless virus or bacterium to deliver pathogen antigens to the host’s cells
    Answer: D.By using a harmless virus or bacterium to deliver pathogen antigens to the host’s cells
  121. 121
    Role of Secretory IgA (sIgA) in Mucosal Immunity
    What is the primary function of secretory IgA in the mucosal surfaces, including the oral cavity?
    • A.To lyse bacterial cells directly
    • B.To enhance the proliferation of immune cells at mucosal surfaces
    • C.To activate complement and induce inflammation
    • D.To neutralize pathogens and prevent their adherence to epithelial surfaces
    Answer: D.To neutralize pathogens and prevent their adherence to epithelial surfaces
  122. 122
    IgA Transport Across Epithelial Cells
    How is secretory IgA transported across epithelial cells into the mucosal surface?
    • A.Via endocytosis and subsequent degradation
    • B.Through the polymeric immunoglobulin receptor (pIgR) pathway
    • C.By passive diffusion through tight junctions
    • D.By active transport using sodium-potassium ATPase
    Answer: B.Through the polymeric immunoglobulin receptor (pIgR) pathway
  123. 123
    Source of Secretory Component in sIgA
    What is the origin of the secretory component found in secretory IgA (sIgA)?
    • A.It is synthesized by macrophages in the mucosal lining
    • B.It is derived from the epithelial cells as part of the pIgR
    • C.It is produced by plasma cells in the mucosal tissue
    • D.It is secreted by dendritic cells during antigen presentation
    Answer: C.It is produced by plasma cells in the mucosal tissue
  124. 124
    Defensive Role of Saliva in the Oral Cavity
    Apart from sIgA, how does saliva contribute to mucosal immunity in the oral cavity?
    • A.By acting as a physical barrier against pathogens
    • B.By containing antimicrobial proteins like lysozyme and lactoferrin
    • C.By promoting bacterial growth to maintain normal flora
    • D.By neutralizing toxins produced by pathogenic bacteria
    Answer: B.By containing antimicrobial proteins like lysozyme and lactoferrin
  125. 125
    IgA Deficiency and Oral Health
    What is a common consequence of selective IgA deficiency in the oral cavity?
    • A.Higher concentration of pro-inflammatory cytokines
    • B.Enhanced secretion of other immunoglobulins
    • C.Lower levels of microbial colonization
    • D.Increased susceptibility to mucosal infections
    Answer: D.Increased susceptibility to mucosal infections
  126. 126
    Polymeric Nature of Secretory IgA
    Why is secretory IgA typically found as a dimer at mucosal surfaces?
    • A.Because dimers have higher affinity for antigen than monomers
    • B.To enhance the inflammatory response at mucosal surfaces
    • C.Because dimeric sIgA is more resistant to enzymatic degradation
    • D.To allow for rapid activation of the complement system
    Answer: C.Because dimeric sIgA is more resistant to enzymatic degradation
  127. 127
    sIgA and Pathogen Neutralization
    How does secretory IgA neutralize pathogens in the oral cavity without causing inflammation?
    • A.By inducing apoptosis in infected epithelial cells
    • B.By producing pro-inflammatory cytokines
    • C.By trapping pathogens in mucus and preventing their adherence to epithelial cells
    • D.By activating complement and recruiting neutrophils
    Answer: C.By trapping pathogens in mucus and preventing their adherence to epithelial cells
  128. 128
    Role of Gut-Associated Lymphoid Tissue (GALT) in IgA Production
    How does the gut-associated lymphoid tissue (GALT) contribute to IgA production at mucosal surfaces, including the oral cavity?
    • A.By inducing systemic immune responses
    • B.By promoting local inflammation and tissue damage
    • C.By priming B cells to secrete IgA, which is then transported to mucosal surfaces
    • D.By secreting IgG antibodies in response to infection
    Answer: C.By priming B cells to secrete IgA, which is then transported to mucosal surfaces
  129. 129
    IgA and Commensal Bacteria in the Oral Cavity
    What role does secretory IgA play in maintaining a balanced microbiome in the oral cavity?
    • A.It increases the production of antimicrobial peptides
    • B.It promotes inflammation to reduce microbial colonization
    • C.It selectively destroys pathogenic bacteria
    • D.It binds to commensal bacteria to limit their overgrowth without inducing an inflammatory response
    Answer: D.It binds to commensal bacteria to limit their overgrowth without inducing an inflammatory response
  130. 130
    Oral Vaccines and IgA Production
    How do oral vaccines stimulate the production of IgA in the mucosal immune system?
    • A.By stimulating systemic IgM production, which triggers IgA release
    • B.By directly increasing the number of dendritic cells at mucosal surfaces
    • C.By inducing antigen presentation in the mucosa, leading to the activation of IgA-producing B cells
    • D.By bypassing the immune system and promoting passive immunity
    Answer: C.By inducing antigen presentation in the mucosa, leading to the activation of IgA-producing B cells
  131. 131
    Antigen-Antibody Complex Formation
    What is the primary force that stabilizes antigen-antibody interactions?
    • A.Hydrogen bonding between antibody heavy and light chains
    • B.Covalent bonding between antigen and antibody
    • C.The enzymatic activity of antibodies on antigens
    • D.Non-covalent interactions such as hydrogen bonds, electrostatic forces, and van der Waals forces
    Answer: D.Non-covalent interactions such as hydrogen bonds, electrostatic forces, and van der Waals forces
  132. 132
    Affinity and Avidity in Antigen-Antibody Binding
    What is the main difference between affinity and avidity in antigen-antibody interactions?
    • A.Affinity refers to the strength of binding between a single antigen and antibody binding site, while avidity refers to the overall binding strength of an antibody with multiple antigen sites
    • B.Avidity refers to the ability of antibodies to undergo clonal expansion in response to antigen
    • C.Affinity is dependent on the number of epitopes, while avidity is not
    • D.Affinity refers to the overall strength of binding of multiple antigen-antibody sites
    Answer: A.Affinity refers to the strength of binding between a single antigen and antibody binding site, while avidity refers to the overall binding strength of an antibody with multiple antigen sites
  133. 133
    Role of the Fab Region in Antigen Recognition
    What role does the Fab region of an antibody play in antigen recognition?
    • A.It mediates effector functions such as complement activation
    • B.It determines the class of the antibody (e.g., IgG, IgM)
    • C.It binds specifically to the antigen’s epitope, determining the specificity of the immune response
    • D.It induces a conformational change in the antigen upon binding
    Answer: C.It binds specifically to the antigen’s epitope, determining the specificity of the immune response
  134. 134
    Agglutination in Diagnostic Tests
    What is the primary use of agglutination reactions in diagnostic tests?
    • A.To detect the presence of particulate antigens or antibodies by visible clumping
    • B.To identify antigen-antibody complexes under fluorescent light
    • C.To determine the tertiary structure of antibodies
    • D.To quantify the concentration of free antibodies in serum
    Answer: A.To detect the presence of particulate antigens or antibodies by visible clumping
  135. 135
    Antigenic Determinants and Antibody Binding
    Which component of an antigen is specifically recognized by an antibody?
    • A.Paratope
    • B.Light chain
    • C.Epitope
    • D.Fc region
    Answer: C.Epitope
  136. 136
    Precipitation Reactions in Immunodiagnostics
    In immunoprecipitation assays, what happens when the concentration of antigen and antibody are equivalent?
    • A.No immune complexes form
    • B.Large, insoluble antigen-antibody complexes form, leading to visible precipitation
    • C.Only small immune complexes form
    • D.Antigen is degraded
    Answer: B.Large, insoluble antigen-antibody complexes form, leading to visible precipitation
  137. 137
    Western Blotting and Antibody Detection
    What is the primary purpose of using antibodies in Western blotting?
    • A.To determine the structure of DNA
    • B.To specifically detect and bind to target proteins that have been separated by electrophoresis
    • C.To induce protein folding after denaturation
    • D.To separate proteins based on size
    Answer: B.To specifically detect and bind to target proteins that have been separated by electrophoresis
  138. 138
    ELISA in Quantifying Antigen-Antibody Reactions
    How does an enzyme-linked immunosorbent assay (ELISA) quantify antigen-antibody interactions?
    • A.By using an enzyme-linked antibody that produces a color change upon substrate conversion, indicating the presence of antigen or antibody
    • B.By measuring the rate of antigen binding
    • C.By inducing the release of cytokines
    • D.By detecting the release of immune complexes in serum
    Answer: A.By using an enzyme-linked antibody that produces a color change upon substrate conversion, indicating the presence of antigen or antibody
  139. 139
    Cross-Reactivity in Antigen-Antibody Interactions
    What is cross-reactivity in the context of antigen-antibody interactions?
    • A.When an antibody binds exclusively to a single antigen
    • B.When an antibody binds to both antigen and complement proteins
    • C.When an antigen is degraded before antibody binding
    • D.When an antibody reacts with multiple antigens due to shared or similar epitopes
    Answer: D.When an antibody reacts with multiple antigens due to shared or similar epitopes
  140. 140
    Monoclonal Antibodies in Diagnostic Testing
    Why are monoclonal antibodies particularly useful in diagnostic testing?
    • A.Because they can alter the genetic material of the antigen
    • B.Because they trigger stronger immune responses
    • C.Because they bind to multiple epitopes on different antigens
    • D.Because they bind to a single, specific epitope with high specificity
    Answer: D.Because they bind to a single, specific epitope with high specificity
  141. 141
    Antigenic Variation in Pathogen Immune Evasion
    How does antigenic variation assist pathogens in evading the host immune system?
    • A.By increasing pathogen replication within host cells
    • B.By producing enzymes that degrade immune cells
    • C.By forming biofilms that shield the pathogen from immune detection
    • D.By altering surface proteins to avoid recognition by antibodies and immune cells
    Answer: D.By altering surface proteins to avoid recognition by antibodies and immune cells
  142. 142
    Role of Latency in Viral Immune Evasion
    How does viral latency enable viruses like Herpes simplex to evade the host immune system?
    • A.By suppressing host immune responses through cytokine release
    • B.By continuously replicating at low levels to avoid detection
    • C.By remaining dormant in host cells, avoiding immune recognition
    • D.By producing proteins that inhibit antigen presentation
    Answer: C.By remaining dormant in host cells, avoiding immune recognition
  143. 143
    Inhibition of Phagocytosis by Bacterial Capsules
    How do bacterial capsules help pathogens evade the immune system?
    • A.By preventing phagocytosis by immune cells
    • B.By enhancing bacterial motility within the host
    • C.By forming resistant spores
    • D.By increasing the production of bacterial toxins
    Answer: A.By preventing phagocytosis by immune cells
  144. 144
    Superantigen Production and Immune Evasion
    How do bacterial superantigens contribute to immune evasion?
    • A.By inducing rapid bacterial replication in host tissues
    • B.By suppressing immune cell recruitment to the site of infection
    • C.By causing nonspecific T-cell activation, leading to immune system overload
    • D.By blocking antibody binding to bacterial surfaces
    Answer: C.By causing nonspecific T-cell activation, leading to immune system overload
  145. 145
    Intracellular Survival of Mycobacterium tuberculosis
    How does Mycobacterium tuberculosis evade the immune response after being phagocytosed by macrophages?
    • A.By altering its surface proteins to evade immune detection
    • B.By escaping from the phagosome into the cytosol
    • C.By secreting enzymes that degrade the phagosome membrane
    • D.By inhibiting the fusion of the phagosome with the lysosome
    Answer: D.By inhibiting the fusion of the phagosome with the lysosome
  146. 146
    Downregulation of MHC Class I by Viruses
    How do certain viruses, such as cytomegalovirus, evade cytotoxic T lymphocytes?
    • A.By downregulating MHC class I molecules, preventing antigen presentation
    • B.By mutating rapidly to avoid immune recognition
    • C.By replicating exclusively in immune-privileged sites
    • D.By infecting cells that lack MHC molecules
    Answer: A.By downregulating MHC class I molecules, preventing antigen presentation
  147. 147
    Biofilm Formation in Bacterial Immune Evasion
    What advantage does biofilm formation provide bacteria in terms of immune evasion?
    • A.It increases the speed of bacterial replication
    • B.It enhances bacterial motility and dissemination
    • C.It decreases the expression of virulence factors
    • D.It shields bacteria from phagocytosis and antimicrobial agents
    Answer: D.It shields bacteria from phagocytosis and antimicrobial agents
  148. 148
    Decoy Receptors in Viral Immune Evasion
    How do some viruses use decoy receptors to evade the host immune response?
    • A.By binding to host immune molecules, preventing them from recognizing the actual pathogen
    • B.By blocking cytokine signaling pathways
    • C.By binding to host immune cells and triggering apoptosis
    • D.By mimicking host cell receptors and redirecting the immune response
    Answer: A.By binding to host immune molecules, preventing them from recognizing the actual pathogen
  149. 149
    Inhibition of Complement Activation by Pathogens
    How do certain pathogens inhibit the activation of the complement system?
    • A.By inducing mutations in host complement proteins
    • B.By binding complement regulatory proteins to their surface, preventing complement activation
    • C.By producing proteins that degrade complement components
    • D.By reducing the expression of complement receptors on immune cells
    Answer: B.By binding complement regulatory proteins to their surface, preventing complement activation
  150. 150
    Molecular Mimicry in Immune Evasion
    What is the role of molecular mimicry in pathogen immune evasion?
    • A.Pathogens produce antigens similar to host molecules, reducing immune recognition
    • B.Pathogens degrade host antibodies to evade the immune response
    • C.Pathogens increase the rate of mutation to escape immune detection
    • D.Pathogens replicate within immune cells to avoid detection
    Answer: A.Pathogens produce antigens similar to host molecules, reducing immune recognition
  151. 151
    Checkpoint Inhibitors in Cancer Immunotherapy
    How do checkpoint inhibitors enhance the immune response against cancer cells?
    • A.By activating cancer-specific B cells
    • B.By increasing the production of cytokines by macrophages
    • C.By blocking inhibitory signals that prevent T-cells from attacking cancer cells
    • D.By directly killing cancer cells
    Answer: C.By blocking inhibitory signals that prevent T-cells from attacking cancer cells
  152. 152
    Monoclonal Antibodies in Cancer Treatment
    What is the primary role of monoclonal antibodies in cancer immunotherapy?
    • A.They enhance antigen presentation by dendritic cells
    • B.They reduce tumor growth by inhibiting angiogenesis
    • C.They boost the production of immune cells in the bone marrow
    • D.They target specific antigens on cancer cells, leading to immune-mediated destruction
    Answer: D.They target specific antigens on cancer cells, leading to immune-mediated destruction
  153. 153
    Mechanism of CAR T-Cell Therapy
    How does CAR T-cell therapy work in treating cancer?
    • A.By modifying a patient's T-cells to express a chimeric antigen receptor that recognizes tumor-specific antigens
    • B.By introducing cancer-specific antibodies into the bloodstream
    • C.By using viral vectors to deliver therapeutic genes to cancer cells
    • D.By enhancing the production of natural killer cells
    Answer: A.By modifying a patient's T-cells to express a chimeric antigen receptor that recognizes tumor-specific antigens
  154. 154
    Cytokine Release Syndrome (CRS) in Immunotherapy
    What causes cytokine release syndrome (CRS) in patients undergoing immunotherapy, such as CAR T-cell therapy?
    • A.Overproduction of immunosuppressive T regulatory cells
    • B.Inhibition of checkpoint proteins
    • C.Rapid activation and proliferation of immune cells, leading to excessive cytokine production
    • D.Decreased activation of macrophages
    Answer: C.Rapid activation and proliferation of immune cells, leading to excessive cytokine production
  155. 155
    Role of PD-1/PD-L1 in Tumor Immune Evasion
    How does the interaction between PD-1 on T-cells and PD-L1 on tumor cells contribute to immune evasion by tumors?
    • A.It decreases the ability of macrophages to phagocytose tumor cells
    • B.It enhances the proliferation of cancer cells by providing growth signals
    • C.It promotes T-cell activation, resulting in tumor cell destruction
    • D.It inhibits T-cell activity, allowing tumor cells to avoid immune destruction
    Answer: D.It inhibits T-cell activity, allowing tumor cells to avoid immune destruction
  156. 156
    Adoptive Cell Transfer in Immunotherapy
    What is adoptive cell transfer (ACT) in the context of cancer immunotherapy?
    • A.The infusion of engineered T-cells to target tumor antigens
    • B.The administration of checkpoint inhibitors to enhance immune response
    • C.The use of monoclonal antibodies to destroy cancer cells
    • D.The collection and expansion of a patient’s own T-cells, which are then reinfused to attack tumors
    Answer: D.The collection and expansion of a patient’s own T-cells, which are then reinfused to attack tumors
  157. 157
    Allergen-Specific Immunotherapy
    What is the goal of allergen-specific immunotherapy in treating allergic diseases?
    • A.To block histamine release from mast cells
    • B.To reduce immune sensitivity to specific allergens by gradually exposing the patient to increasing doses of the allergen
    • C.To inhibit T-cell activity in response to allergens
    • D.To increase IgE production in response to the allergen
    Answer: B.To reduce immune sensitivity to specific allergens by gradually exposing the patient to increasing doses of the allergen
  158. 158
    Role of Regulatory T-Cells in Immunotherapy
    How do regulatory T-cells (Tregs) influence the effectiveness of cancer immunotherapy?
    • A.By enhancing antibody production against tumor antigens
    • B.By directly killing tumor cells
    • C.By promoting immune activation and inflammation
    • D.By suppressing the immune response and limiting the effectiveness of the therapy
    Answer: D.By suppressing the immune response and limiting the effectiveness of the therapy
  159. 159
    Immune Checkpoint Blockade Resistance
    What is a common mechanism by which tumors develop resistance to immune checkpoint blockade therapies?
    • A.Upregulation of alternative immune checkpoints
    • B.Enhanced production of chemokines
    • C.Mutations in T-cell receptors
    • D.Increased expression of tumor-specific antigens
    Answer: A.Upregulation of alternative immune checkpoints
  160. 160
    Desensitization Therapy for Allergies
    What is the primary mechanism of desensitization therapy in the treatment of allergies?
    • A.By inhibiting the production of cytokines
    • B.By promoting histamine release in response to allergens
    • C.By increasing the production of IgE antibodies
    • D.By inducing tolerance through repeated exposure to small amounts of the allergen
    Answer: D.By inducing tolerance through repeated exposure to small amounts of the allergen
  161. 161
    Role of Molecular Mimicry in Autoimmune Disease
    How does molecular mimicry contribute to the development of autoimmune diseases?
    • A.By preventing the immune system from recognizing self-antigens
    • B.By causing cross-reactivity between pathogen antigens and host tissues, leading to autoimmunity
    • C.By increasing the production of T regulatory cells
    • D.By directly attacking immune cells
    Answer: B.By causing cross-reactivity between pathogen antigens and host tissues, leading to autoimmunity
  162. 162
    Pathogenesis of Rheumatoid Arthritis (RA)
    What is a key feature of the pathogenesis of rheumatoid arthritis?
    • A.The formation of immune complexes and synovial inflammation
    • B.The destruction of pancreatic beta cells by autoreactive T-cells
    • C.The overproduction of immunoglobulin G (IgG) leading to tissue damage
    • D.The activation of cytotoxic T-cells targeting myelin sheaths
    Answer: A.The formation of immune complexes and synovial inflammation
  163. 163
    Autoantibody Production in Systemic Lupus Erythematosus (SLE)
    What is the significance of autoantibody production in systemic lupus erythematosus (SLE)?
    • A.Autoantibodies, such as anti-dsDNA, target nuclear components, leading to widespread tissue damage
    • B.Autoantibodies neutralize cytokines, causing immunosuppression
    • C.Autoantibodies increase the clearance of immune complexes from the bloodstream
    • D.Autoantibodies stimulate the production of regulatory T cells
    Answer: A.Autoantibodies, such as anti-dsDNA, target nuclear components, leading to widespread tissue damage
  164. 164
    Role of Environmental Factors in Autoimmune Disease
    Which environmental factor has been implicated in triggering autoimmune diseases in genetically predisposed individuals?
    • A.High altitude exposure
    • B.Viral infections, such as Epstein-Barr virus (EBV)
    • C.Excessive physical exercise
    • D.High protein diets
    Answer: B.Viral infections, such as Epstein-Barr virus (EBV)
  165. 165
    Function of Regulatory T Cells in Autoimmunity
    How do regulatory T cells (Tregs) prevent the development of autoimmune diseases?
    • A.By promoting the proliferation of B cells
    • B.By suppressing autoreactive T-cells and maintaining immune tolerance
    • C.By enhancing the activation of cytotoxic T-cells
    • D.By producing large amounts of antibodies
    Answer: B.By suppressing autoreactive T-cells and maintaining immune tolerance
  166. 166
    Genetic Susceptibility in Autoimmune Disease
    How does the presence of certain HLA alleles influence the risk of developing autoimmune diseases?
    • A.By altering the structure of B cell receptors
    • B.By preventing the immune system from recognizing pathogens
    • C.By presenting self-antigens to T cells, leading to autoimmunity
    • D.By decreasing the expression of MHC class I molecules
    Answer: C.By presenting self-antigens to T cells, leading to autoimmunity
  167. 167
    Cytokines and Inflammation in Autoimmune Disease
    Which cytokine is commonly elevated in autoimmune diseases such as rheumatoid arthritis, contributing to inflammation and joint destruction?
    • A.Tumor necrosis factor-alpha (TNF-α)
    • B.IL-4
    • C.Interferon-gamma (IFN-γ)
    • D.IL-10
    Answer: A.Tumor necrosis factor-alpha (TNF-α)
  168. 168
    Autoimmune Hemolytic Anemia Pathogenesis
    What is the primary mechanism underlying autoimmune hemolytic anemia?
    • A.The inhibition of platelet production in the bone marrow
    • B.The destruction of pancreatic beta cells by autoreactive T cells
    • C.The production of autoantibodies that target red blood cells, leading to their destruction
    • D.The production of antibodies that inhibit erythropoiesis
    Answer: C.The production of autoantibodies that target red blood cells, leading to their destruction
  169. 169
    Complement Activation in Systemic Lupus Erythematosus (SLE)
    How does complement activation contribute to the pathogenesis of systemic lupus erythematosus (SLE)?
    • A.By amplifying inflammation and tissue damage through the formation of membrane attack complexes (MACs)
    • B.By preventing immune complex formation
    • C.By blocking B-cell maturation
    • D.By enhancing the clearance of apoptotic cells
    Answer: A.By amplifying inflammation and tissue damage through the formation of membrane attack complexes (MACs)
  170. 170
    Antigenic Targets in Multiple Sclerosis (MS)
    What is the primary target of the immune response in multiple sclerosis (MS)?
    • A.The myelin sheath surrounding central nervous system neurons
    • B.The insulin-producing beta cells of the pancreas
    • C.The epithelial cells lining the respiratory tract
    • D.The endothelial cells of blood vessels
    Answer: A.The myelin sheath surrounding central nervous system neurons
  171. 171
    Type I Hypersensitivity Reaction
    What immune component is primarily involved in mediating a Type I hypersensitivity reaction, such as anaphylaxis?
    • A.Immune complexes
    • B.IgE antibodies binding to mast cells and basophils
    • C.Cytotoxic T cells
    • D.IgG antibodies
    Answer: B.IgE antibodies binding to mast cells and basophils
  172. 172
    Role of Histamine in Allergic Reactions
    What is the primary effect of histamine release during an allergic reaction?
    • A.Blocking the release of cytokines from immune cells
    • B.Increasing vascular permeability and causing vasodilation
    • C.Enhancing the destruction of pathogens by macrophages
    • D.Inducing T-cell proliferation
    Answer: B.Increasing vascular permeability and causing vasodilation
  173. 173
    Antigen in Allergic Reactions
    What role does the antigen play in the initiation of an allergic reaction?
    • A.It blocks immune responses to pathogens
    • B.It stimulates the production of cytotoxic T cells
    • C.It triggers the initial sensitization by binding to IgE on mast cells
    • D.It binds directly to histamine receptors on immune cells
    Answer: C.It triggers the initial sensitization by binding to IgE on mast cells
  174. 174
    Late-Phase Allergic Reaction
    What causes the late-phase response in allergic reactions?
    • A.Recruitment of eosinophils and other inflammatory cells to the site of allergen exposure
    • B.Immediate release of histamine from mast cells
    • C.IgE antibodies neutralizing the allergen
    • D.Degranulation of basophils releasing proteolytic enzymes
    Answer: A.Recruitment of eosinophils and other inflammatory cells to the site of allergen exposure
  175. 175
    Anaphylaxis Management
    What is the first-line treatment for anaphylaxis?
    • A.Intramuscular injection of epinephrine
    • B.Intravenous corticosteroids
    • C.Oral antihistamines
    • D.Oxygen therapy
    Answer: A.Intramuscular injection of epinephrine
  176. 176
    Type IV Hypersensitivity Reaction
    What differentiates a Type IV hypersensitivity reaction, such as contact dermatitis, from other allergic reactions?
    • A.It occurs immediately upon exposure to the allergen
    • B.It is mediated by IgE antibodies
    • C.It involves immune complexes
    • D.It is delayed and primarily mediated by T cells
    Answer: D.It is delayed and primarily mediated by T cells
  177. 177
    Use of Corticosteroids in Allergic Reactions
    How do corticosteroids manage allergic reactions?
    • A.By preventing the binding of IgE to mast cells
    • B.By blocking histamine receptors on immune cells
    • C.By reducing inflammation through inhibition of cytokine production
    • D.By directly neutralizing the allergen
    Answer: C.By reducing inflammation through inhibition of cytokine production
  178. 178
    Allergen-Specific Immunotherapy (Desensitization)
    What is the primary goal of allergen-specific immunotherapy?
    • A.To block the release of histamine from mast cells
    • B.To prevent the production of IgE antibodies
    • C.To induce immune tolerance by gradually exposing the patient to increasing amounts of the allergen
    • D.To prevent the activation of complement proteins
    Answer: C.To induce immune tolerance by gradually exposing the patient to increasing amounts of the allergen
  179. 179
    Role of Leukotrienes in Allergic Reactions
    How do leukotrienes contribute to the pathophysiology of allergic reactions?
    • A.By directly deactivating mast cells
    • B.By blocking histamine release from basophils
    • C.By neutralizing the allergen in the bloodstream
    • D.By increasing bronchoconstriction, vascular permeability, and mucus production
    Answer: D.By increasing bronchoconstriction, vascular permeability, and mucus production
  180. 180
    Antihistamines in Allergy Management
    How do antihistamines alleviate symptoms of allergic reactions?
    • A.By increasing the metabolism of histamine in the liver
    • B.By suppressing IgE production in B cells
    • C.By blocking histamine receptors, preventing histamine from binding to its target
    • D.By inhibiting the recruitment of T cells to the site of allergen exposure
    Answer: C.By blocking histamine receptors, preventing histamine from binding to its target
  181. 181
    Regulatory T Cells (Tregs) in Immune Homeostasis
    How do regulatory T cells (Tregs) contribute to immune homeostasis?
    • A.By promoting the release of pro-inflammatory cytokines
    • B.By enhancing the activation of effector T cells
    • C.By suppressing the activation and proliferation of autoreactive T cells
    • D.By directly killing pathogens in the bloodstream
    Answer: C.By suppressing the activation and proliferation of autoreactive T cells
  182. 182
    FoxP3 and Treg Function
    What is the role of the transcription factor FoxP3 in regulatory T cells?
    • A.It suppresses the expression of surface markers on Tregs
    • B.It is essential for the development and function of Tregs
    • C.It enhances cytokine production in effector T cells
    • D.It promotes the differentiation of effector T cells
    Answer: B.It is essential for the development and function of Tregs
  183. 183
    Mechanism of Treg-Mediated Suppression
    Which of the following is a key mechanism by which Tregs suppress immune responses?
    • A.By promoting the activation of natural killer (NK) cells
    • B.By inhibiting the expression of FoxP3 in effector T cells
    • C.By increasing the production of pro-inflammatory cytokines
    • D.By secreting anti-inflammatory cytokines such as IL-10 and TGF-β
    Answer: D.By secreting anti-inflammatory cytokines such as IL-10 and TGF-β
  184. 184
    Role of Tregs in Autoimmune Diseases
    How does a deficiency in Tregs contribute to the development of autoimmune diseases?
    • A.By promoting tolerance to self-antigens
    • B.By failing to suppress autoreactive immune cells, leading to tissue damage
    • C.By increasing the production of antibodies against pathogens
    • D.By reducing the proliferation of autoreactive B cells
    Answer: B.By failing to suppress autoreactive immune cells, leading to tissue damage
  185. 185
    Treg Development in the Thymus
    What is the role of the thymus in Treg development?
    • A.It prevents the migration of Tregs to peripheral tissues
    • B.It allows for the differentiation of Tregs into effector T cells
    • C.It produces pro-inflammatory cytokines that enhance Treg function
    • D.It is where thymic Tregs are selected based on their ability to recognize self-antigens
    Answer: D.It is where thymic Tregs are selected based on their ability to recognize self-antigens
  186. 186
    CTLA-4 and Treg Function
    How does CTLA-4 contribute to the immunosuppressive function of Tregs?
    • A.By increasing Treg proliferation
    • B.By inhibiting costimulatory signals required for effector T cell activation
    • C.By enhancing the secretion of IL-2
    • D.By inhibiting the differentiation of Tregs
    Answer: B.By inhibiting costimulatory signals required for effector T cell activation
  187. 187
    Tregs in Tumor Immunology
    What role do Tregs play in the tumor microenvironment?
    • A.They promote the migration of immune cells to the tumor site
    • B.They suppress the immune response against tumor cells, promoting tumor growth
    • C.They enhance the activity of cytotoxic T cells
    • D.They increase the expression of tumor-specific antigens
    Answer: B.They suppress the immune response against tumor cells, promoting tumor growth
  188. 188
    Peripheral Tolerance and Tregs
    How do Tregs maintain peripheral tolerance to self-antigens?
    • A.By suppressing autoreactive T cells in peripheral tissues
    • B.By enhancing the differentiation of effector T cells
    • C.By inducing apoptosis in effector T cells
    • D.By increasing the activation of dendritic cells
    Answer: A.By suppressing autoreactive T cells in peripheral tissues
  189. 189
    Treg Dysregulation and Inflammatory Diseases
    How does dysregulation of Treg function contribute to chronic inflammatory diseases?
    • A.By increasing the production of IL-10
    • B.By failing to suppress pro-inflammatory responses, leading to tissue damage
    • C.By enhancing the differentiation of Tregs into effector T cells
    • D.By promoting the clearance of infections
    Answer: B.By failing to suppress pro-inflammatory responses, leading to tissue damage
  190. 190
    Therapeutic Targeting of Tregs in Autoimmune Diseases
    How can enhancing Treg function be a potential therapeutic strategy for autoimmune diseases?
    • A.By increasing the activity of effector T cells against self-antigens
    • B.By promoting immune tolerance and reducing inflammation
    • C.By inhibiting Treg migration to affected tissues
    • D.By decreasing the production of anti-inflammatory cytokines
    Answer: B.By promoting immune tolerance and reducing inflammation
  191. 191
    Role of T Cells in Periodontitis
    How do T cells contribute to the pathogenesis of periodontitis?
    • A.By preventing the activation of B cells and antibody production
    • B.By releasing pro-inflammatory cytokines that drive tissue destruction
    • C.By producing cytokines that promote tissue regeneration
    • D.By inhibiting neutrophil migration to the site of infection
    Answer: B.By releasing pro-inflammatory cytokines that drive tissue destruction
  192. 192
    Neutrophil Function in Gingivitis
    What is the primary role of neutrophils in gingivitis?
    • A.To secrete antibodies that neutralize bacterial toxins
    • B.To prevent the migration of lymphocytes to the inflamed site
    • C.To act as the first line of defense by phagocytosing bacteria in the gingival crevice
    • D.To promote tissue repair by releasing growth factors
    Answer: C.To act as the first line of defense by phagocytosing bacteria in the gingival crevice
  193. 193
    Cytokine Release in Gingival Inflammation
    Which cytokine is most commonly associated with promoting inflammation in gingivitis?
    • A.Transforming growth factor-beta (TGF-β)
    • B.Interleukin-1 (IL-1)
    • C.Tumor necrosis factor-alpha (TNF-α)
    • D.Interleukin-10 (IL-10)
    Answer: B.Interleukin-1 (IL-1)
  194. 194
    Antibody Response in Chronic Periodontitis
    What role do antibodies play in chronic periodontitis?
    • A.They are ineffective at halting tissue destruction and may contribute to disease progression
    • B.They block inflammatory signaling pathways
    • C.They promote phagocytosis by binding to bacterial surface antigens
    • D.They neutralize bacterial toxins and prevent further infection
    Answer: A.They are ineffective at halting tissue destruction and may contribute to disease progression
  195. 195
    Role of Matrix Metalloproteinases (MMPs) in Periodontitis
    How do matrix metalloproteinases (MMPs) contribute to tissue destruction in periodontitis?
    • A.By preventing the migration of immune cells to the site of infection
    • B.By enhancing the production of anti-inflammatory cytokines
    • C.By degrading the extracellular matrix components such as collagen
    • D.By stimulating the proliferation of fibroblasts
    Answer: C.By degrading the extracellular matrix components such as collagen
  196. 196
    Th17 Cells in Periodontal Disease
    What is the role of Th17 cells in the immune response during periodontal disease?
    • A.They prevent bacterial adhesion to gingival tissues
    • B.They suppress immune responses to maintain homeostasis
    • C.They contribute to inflammation by secreting IL-17, which recruits neutrophils and enhances tissue destruction
    • D.They promote tissue regeneration through growth factor release
    Answer: C.They contribute to inflammation by secreting IL-17, which recruits neutrophils and enhances tissue destruction
  197. 197
    Bacterial Biofilm and Host Immune Response
    How does the presence of bacterial biofilms in the gingival sulcus affect the host immune response in periodontitis?
    • A.It prevents the activation of T cells in the periodontal pocket
    • B.It enhances the chronic inflammatory response by continuously activating immune cells
    • C.It neutralizes the activity of neutrophils and macrophages
    • D.It reduces the immune response by preventing immune cell migration
    Answer: B.It enhances the chronic inflammatory response by continuously activating immune cells
  198. 198
    Role of Regulatory T Cells (Tregs) in Periodontal Health
    How do regulatory T cells (Tregs) contribute to periodontal health?
    • A.By enhancing antibody production against periodontal pathogens
    • B.By suppressing excessive immune responses and preventing tissue damage
    • C.By stimulating neutrophil activity
    • D.By promoting bone resorption through cytokine production
    Answer: B.By suppressing excessive immune responses and preventing tissue damage
  199. 199
    Osteoclast Activity in Periodontitis
    What is the primary mechanism through which osteoclasts contribute to bone loss in periodontitis?
    • A.By resorbing alveolar bone in response to inflammatory cytokines like RANKL
    • B.By degrading the surrounding soft tissue
    • C.By enhancing the proliferation of fibroblasts
    • D.By stimulating the production of anti-inflammatory cytokines
    Answer: A.By resorbing alveolar bone in response to inflammatory cytokines like RANKL
  200. 200
    Role of IL-10 in Periodontal Inflammation
    How does the anti-inflammatory cytokine IL-10 affect periodontal disease progression?
    • A.By downregulating pro-inflammatory cytokine production and limiting tissue destruction
    • B.By promoting bacterial adhesion to gingival tissues
    • C.By increasing collagen degradation in the periodontal ligament
    • D.By enhancing the recruitment of neutrophils to the site of infection
    Answer: A.By downregulating pro-inflammatory cytokine production and limiting tissue destruction
  201. 201
    Mechanism of Action of Monoclonal Antibodies
    How do monoclonal antibodies primarily exert their therapeutic effects?
    • A.By neutralizing toxins produced by pathogens
    • B.By blocking all protein synthesis in the target cell
    • C.By specifically binding to antigens on target cells, marking them for destruction by the immune system
    • D.By directly killing cancer cells
    Answer: C.By specifically binding to antigens on target cells, marking them for destruction by the immune system
  202. 202
    Humanization of Monoclonal Antibodies
    Why are many monoclonal antibodies "humanized" before therapeutic use in humans?
    • A.To reduce the immune response against the antibody itself
    • B.To enhance their ability to cross the blood-brain barrier
    • C.To increase their half-life in the bloodstream
    • D.To increase their ability to bind to human antigens
    Answer: A.To reduce the immune response against the antibody itself
  203. 203
    Targeted Therapy in Cancer
    How do monoclonal antibodies function as targeted therapies in cancer treatment?
    • A.By specifically binding to cancer cell antigens and blocking cell growth or inducing apoptosis
    • B.By activating T cells to attack healthy cells
    • C.By directly enhancing the proliferation of normal cells
    • D.By increasing the sensitivity of cancer cells to chemotherapy
    Answer: A.By specifically binding to cancer cell antigens and blocking cell growth or inducing apoptosis
  204. 204
    Mechanism of Immune Checkpoint Inhibitors
    What is the mechanism by which monoclonal antibodies targeting immune checkpoints, such as PD-1 or CTLA-4, enhance anti-tumor immunity?
    • A.By blocking inhibitory signals that prevent T cells from attacking tumor cells
    • B.By increasing the production of antibodies against tumor cells
    • C.By increasing the number of regulatory T cells
    • D.By preventing tumor cells from producing toxins
    Answer: A.By blocking inhibitory signals that prevent T cells from attacking tumor cells
  205. 205
    Antibody-Drug Conjugates (ADCs)
    What is the therapeutic advantage of antibody-drug conjugates (ADCs)?
    • A.They enhance the immune system’s ability to detect cancer cells
    • B.They prevent angiogenesis in tumor environments
    • C.They deliver cytotoxic drugs directly to cancer cells via antibody targeting, minimizing damage to normal cells
    • D.They increase the half-life of chemotherapeutic agents
    Answer: C.They deliver cytotoxic drugs directly to cancer cells via antibody targeting, minimizing damage to normal cells
  206. 206
    Monoclonal Antibodies in Autoimmune Diseases
    How do monoclonal antibodies used to treat autoimmune diseases, such as rheumatoid arthritis, function?
    • A.By increasing the production of inflammatory cytokines
    • B.By promoting the proliferation of T cells
    • C.By enhancing immune cell activity against autoantigens
    • D.By blocking specific immune system molecules involved in the inflammatory response, such as TNF-α
    Answer: D.By blocking specific immune system molecules involved in the inflammatory response, such as TNF-α
  207. 207
    Antibody-Dependent Cellular Cytotoxicity (ADCC)
    What is the role of antibody-dependent cellular cytotoxicity (ADCC) in the action of therapeutic monoclonal antibodies?
    • A.It increases the production of cytokines in the target cell
    • B.It involves the recruitment of immune cells like natural killer cells to destroy antibody-coated target cells
    • C.It directly induces apoptosis in tumor cells
    • D.It prevents the spread of cancer to other tissues
    Answer: B.It involves the recruitment of immune cells like natural killer cells to destroy antibody-coated target cells
  208. 208
    Chimeric Antigen Receptor (CAR) T-Cell Therapy
    How are monoclonal antibodies used in conjunction with CAR T-cell therapy?
    • A.By guiding CAR T-cells to the specific antigens on tumor cells, enhancing their activity
    • B.By preventing immune cells from attacking normal tissues
    • C.By reducing the immune response against the CAR T-cells
    • D.By directly lysing cancer cells through the CAR mechanism
    Answer: A.By guiding CAR T-cells to the specific antigens on tumor cells, enhancing their activity
  209. 209
    Monoclonal Antibodies and Drug Resistance
    What is a potential mechanism by which cancer cells can develop resistance to monoclonal antibody therapy?
    • A.By downregulating or mutating the antigen targeted by the monoclonal antibody
    • B.By enhancing the production of antibodies against the therapy
    • C.By increasing the number of regulatory T cells
    • D.By decreasing the number of immune cells in the tumor microenvironment
    Answer: A.By downregulating or mutating the antigen targeted by the monoclonal antibody
  210. 210
    Monoclonal Antibodies Against Infectious Diseases
    How are monoclonal antibodies used therapeutically against infectious diseases like COVID-19?
    • A.By blocking cytokine release syndrome
    • B.By directly destroying viral particles through ADCC
    • C.By increasing the host’s immune response against the virus
    • D.By binding to viral proteins and neutralizing the virus, preventing infection
    Answer: D.By binding to viral proteins and neutralizing the virus, preventing infection
  211. 211
    Thymus and T-Cell Maturation
    What is the primary role of the thymus in the immune system?
    • A.To produce B-cells
    • B.To facilitate the maturation and differentiation of T-cells
    • C.To activate neutrophils in response to infection
    • D.To filter lymph
    Answer: B.To facilitate the maturation and differentiation of T-cells
  212. 212
    Thymic Involution and Immunity
    What happens to the thymus during aging, and how does it impact the immune system?
    • A.It begins to produce fewer antibodies
    • B.It undergoes involution, reducing T-cell output
    • C.It increases in size, enhancing immune function
    • D.It produces more B-cells to compensate for declining immunity
    Answer: B.It undergoes involution, reducing T-cell output
  213. 213
    Positive Selection in the Thymus
    During T-cell development, what is the purpose of positive selection in the thymus?
    • A.To eliminate T-cells that react too strongly to self-antigens
    • B.To destroy T-cells that fail to bind to antigens
    • C.To ensure that T-cells can recognize self-MHC molecules
    • D.To activate B-cells for antibody production
    Answer: C.To ensure that T-cells can recognize self-MHC molecules
  214. 214
    Negative Selection and Autoimmunity Prevention
    What is the function of negative selection in the thymus?
    • A.To activate T-cells that bind weakly to self-antigens
    • B.To eliminate T-cells that strongly react to self-antigens, preventing autoimmunity
    • C.To prevent T-cell apoptosis
    • D.To increase T-cell receptor diversity
    Answer: B.To eliminate T-cells that strongly react to self-antigens, preventing autoimmunity
  215. 215
    Thymic Cortex vs. Medulla in T-Cell Development
    Where does positive selection primarily occur during T-cell development in the thymus?
    • A.Bone marrow
    • B.Thymic medulla
    • C.Thymic cortex
    • D.Lymph nodes
    Answer: C.Thymic cortex
  216. 216
    Role of AIRE in Central Tolerance
    What is the role of the autoimmune regulator (AIRE) gene in the thymus?
    • A.It aids in positive selection of T-cells
    • B.It promotes B-cell maturation in the bone marrow
    • C.It ensures the presentation of peripheral tissue antigens for negative selection, preventing autoimmunity
    • D.It stimulates cytokine production in mature T-cells
    Answer: C.It ensures the presentation of peripheral tissue antigens for negative selection, preventing autoimmunity
  217. 217
    DiGeorge Syndrome and Thymic Development
    Which immune defect is associated with DiGeorge syndrome?
    • A.Thymic hypoplasia, leading to impaired T-cell development
    • B.Overproduction of mature T-cells
    • C.Lack of cytokine production in lymph nodes
    • D.Increased B-cell function and antibody production
    Answer: A.Thymic hypoplasia, leading to impaired T-cell development
  218. 218
    Thymus-Derived Regulatory T-Cells
    How do regulatory T-cells (Tregs), which are derived from the thymus, contribute to immune tolerance?
    • A.By enhancing the activation of cytotoxic T-cells
    • B.By promoting inflammation during infection
    • C.By stimulating the production of autoantibodies
    • D.By suppressing the activity of self-reactive T-cells
    Answer: D.By suppressing the activity of self-reactive T-cells
  219. 219
    Thymic Epithelial Cells and T-Cell Education
    What role do thymic epithelial cells play in T-cell development?
    • A.They directly produce cytokines that activate T-cells
    • B.They present self-antigens to developing T-cells during positive and negative selection
    • C.They secrete antibodies to guide T-cell maturation
    • D.They act as antigen-presenting cells in peripheral tissues
    Answer: B.They present self-antigens to developing T-cells during positive and negative selection
  220. 220
    Thymectomy and Immune Function
    What is the expected immune outcome in an adult who undergoes thymectomy (removal of the thymus)?
    • A.Minimal impact, as the thymus has already produced sufficient mature T-cells
    • B.Permanent suppression of B-cell production
    • C.Complete loss of immune function
    • D.Increased susceptibility to bacterial infections
    Answer: A.Minimal impact, as the thymus has already produced sufficient mature T-cells
  221. 221
    What is the primary function of Neutrophil Extracellular Traps (NETs) in the immune response?
    • A.To enhance antigen presentation
    • B.To promote phagocytosis by dendritic cells
    • C.To trap and kill pathogens by releasing chromatin structures and antimicrobial proteins
    • D.To facilitate neutrophil migration
    Answer: C.To trap and kill pathogens by releasing chromatin structures and antimicrobial proteins
  222. 222
    Phagocytosis Mechanism in Macrophages
    Which of the following best describes the mechanism by which macrophages engulf pathogens?
    • A.Pathogen lysis occurs before phagocytosis
    • B.Opsonization enhances the recognition and engulfment of pathogens by macrophages
    • C.Antibody binding stimulates endocytosis
    • D.Macrophages release toxins to kill pathogens before phagocytosis
    Answer: B.Opsonization enhances the recognition and engulfment of pathogens by macrophages
  223. 223
    Dendritic Cells and Antigen Presentation
    What is the primary role of dendritic cells in the immune response?
    • A.To directly kill pathogens via phagocytosis
    • B.To release cytokines and initiate inflammation
    • C.To activate B cells in the lymph nodes
    • D.To capture and present antigens to T cells, initiating the adaptive immune response
    Answer: D.To capture and present antigens to T cells, initiating the adaptive immune response
  224. 224
    Oxidative Burst in Phagocytes
    What role does the oxidative burst play in the function of phagocytes?
    • A.It generates reactive oxygen species to kill engulfed pathogens
    • B.It inhibits the production of inflammatory cytokines
    • C.It helps in antigen presentation
    • D.It stimulates neutrophil recruitment to the infection site
    Answer: A.It generates reactive oxygen species to kill engulfed pathogens
  225. 225
    Macrophage Polarization
    What is the function of M2 macrophages during tissue repair?
    • A.They secrete pro-inflammatory cytokines to recruit more immune cells
    • B.They promote tissue repair and anti-inflammatory responses
    • C.They induce antigen presentation and stimulate T cell activation
    • D.They release reactive oxygen species to destroy pathogens
    Answer: B.They promote tissue repair and anti-inflammatory responses
  226. 226
    Cross-Presentation by Dendritic Cells
    What is cross-presentation in dendritic cells?
    • A.Presentation of extracellular antigens on MHC class II molecules
    • B.Transfer of antigens between dendritic cells and neutrophils
    • C.Presentation of self-antigens to prevent autoimmune responses
    • D.Presentation of extracellular antigens on MHC class I molecules to activate CD8+ T cells
    Answer: D.Presentation of extracellular antigens on MHC class I molecules to activate CD8+ T cells
  227. 227
    Neutrophil Life Span and Function
    What limits the lifespan of neutrophils in peripheral tissues?
    • A.Their short half-life and rapid apoptosis after pathogen clearance
    • B.Exhaustion of phagocytic receptors
    • C.Inability to exit the circulatory system
    • D.Rapid depletion of their lysosomal enzymes
    Answer: A.Their short half-life and rapid apoptosis after pathogen clearance
  228. 228
    Macrophages and Chronic Inflammation
    How do macrophages contribute to chronic inflammation?
    • A.By persistently secreting pro-inflammatory cytokines in response to unresolved infection
    • B.By continuously recruiting neutrophils to the site of infection
    • C.By differentiating into neutrophils in response to persistent stimuli
    • D.By phagocytosing pathogens and rapidly resolving inflammation
    Answer: A.By persistently secreting pro-inflammatory cytokines in response to unresolved infection
  229. 229
    Role of Dendritic Cells in T Cell Activation
    How do dendritic cells ensure effective activation of T cells in lymphoid organs?
    • A.By migrating to the spleen and directly killing pathogens
    • B.By secreting antibodies that stimulate T cells
    • C.By expressing both co-stimulatory molecules and presenting processed antigens to T cells
    • D.By producing chemokines that attract T cells to the infection site
    Answer: C.By expressing both co-stimulatory molecules and presenting processed antigens to T cells
  230. 230
    Phagosome-Lysosome Fusion in Neutrophils
    What is the significance of phagosome-lysosome fusion in neutrophils?
    • A.It stimulates dendritic cell migration to the infection site
    • B.It enhances antigen presentation to B cells
    • C.It initiates the release of antibodies into the bloodstream
    • D.It allows the degradation of pathogens by lysosomal enzymes
    Answer: D.It allows the degradation of pathogens by lysosomal enzymes
  231. 231
    Role of Interferons in Viral Infection Control
    What is the primary role of Type I interferons (IFN-α and IFN-β) during a viral infection?
    • A.To suppress the immune response and prevent inflammation
    • B.To increase the production of antibodies
    • C.To promote viral replication within host cells
    • D.To inhibit viral replication and enhance immune cell activity
    Answer: D.To inhibit viral replication and enhance immune cell activity
  232. 232
    Cytotoxic T Cells and Viral Clearance
    How do cytotoxic T lymphocytes (CTLs) contribute to the clearance of viral infections?
    • A.By producing antibodies that neutralize the virus
    • B.By inducing apoptosis in uninfected cells
    • C.By recognizing and destroying virus-infected cells through perforin and granzyme release
    • D.By presenting viral antigens to helper T cells
    Answer: C.By recognizing and destroying virus-infected cells through perforin and granzyme release
  233. 233
    Antibody-Mediated Neutralization of Viruses
    What is the primary mechanism by which antibodies neutralize viral particles?
    • A.By directly destroying the viral genome
    • B.By preventing viral transcription
    • C.By promoting viral replication within host immune cells
    • D.By binding to viral surface proteins, preventing the virus from entering host cells
    Answer: D.By binding to viral surface proteins, preventing the virus from entering host cells
  234. 234
    Role of NK Cells in Early Viral Infection
    What is the role of natural killer (NK) cells during the early stages of a viral infection?
    • A.They produce antibodies against the virus
    • B.They kill virus-infected cells by detecting the absence of MHC class I molecules
    • C.They secrete interferon-gamma to activate macrophages
    • D.They promote viral entry into cells
    Answer: B.They kill virus-infected cells by detecting the absence of MHC class I molecules
  235. 235
    Helper T Cells in Viral Infections
    How do CD4+ helper T cells aid in the immune response to viral infections?
    • A.By activating B cells to produce antibodies
    • B.By inhibiting the immune response to prevent tissue damage
    • C.By increasing viral replication within the host
    • D.By directly lysing infected cells
    Answer: A.By activating B cells to produce antibodies
  236. 236
    Viral Evasion of the Immune System
    Which strategy do viruses often use to evade detection by the host immune system?
    • A.Downregulating MHC class I molecules to avoid CTL recognition
    • B.Increasing host cell apoptosis
    • C.Stimulating the production of immune cells
    • D.Enhancing MHC class I expression
    Answer: A.Downregulating MHC class I molecules to avoid CTL recognition
  237. 237
    Role of IFN-γ in Viral Infections
    How does interferon-gamma (IFN-γ) contribute to the immune response against viral infections?
    • A.By directly killing virus-infected cells
    • B.By increasing the rate of viral replication
    • C.By activating macrophages and promoting antigen presentation
    • D.By inhibiting the immune response
    Answer: C.By activating macrophages and promoting antigen presentation
  238. 238
    Memory T Cells and Viral Infections
    What role do memory T cells play in response to a recurrent viral infection?
    • A.They prevent the virus from entering the host cells
    • B.They destroy all infected cells indiscriminately
    • C.They increase the production of antibodies
    • D.They quickly respond to subsequent infections by recognizing viral antigens more rapidly
    Answer: D.They quickly respond to subsequent infections by recognizing viral antigens more rapidly
  239. 239
    Viral Latency and Immune Evasion
    How does viral latency contribute to immune evasion?
    • A.By allowing the virus to persist in host cells without being detected by the immune system
    • B.By exposing viral antigens to the immune system
    • C.By enhancing the production of viral particles during latency
    • D.By preventing viral genome replication
    Answer: A.By allowing the virus to persist in host cells without being detected by the immune system
  240. 240
    Cross-Presentation in Viral Immunity
    How does cross-presentation aid in the immune response to viral infections?
    • A.It allows dendritic cells to present extracellular viral antigens on MHC class I molecules, activating cytotoxic T cells
    • B.It increases the rate of viral replication within infected cells
    • C.It stimulates B cells to produce neutralizing antibodies
    • D.It decreases the production of memory T cells
    Answer: A.It allows dendritic cells to present extracellular viral antigens on MHC class I molecules, activating cytotoxic T cells
  241. 241
    Gut Microbiome and Immune Homeostasis
    How does the gut microbiome primarily contribute to immune homeostasis?
    • A.By increasing the permeability of the intestinal barrier
    • B.By enhancing the growth of pathogenic bacteria in the intestines
    • C.By directly stimulating the production of antibodies against pathogens
    • D.By regulating the development and function of immune cells such as T-regulatory cells
    Answer: D.By regulating the development and function of immune cells such as T-regulatory cells
  242. 242
    Short-Chain Fatty Acids (SCFAs) and Immune Modulation
    What is the role of short-chain fatty acids (SCFAs) produced by gut microbes in immune function?
    • A.They inhibit the growth of beneficial gut bacteria
    • B.They promote anti-inflammatory responses by supporting T-regulatory cells
    • C.They enhance the production of inflammatory cytokines
    • D.They increase the permeability of the gut lining
    Answer: B.They promote anti-inflammatory responses by supporting T-regulatory cells
  243. 243
    Gut-Associated Lymphoid Tissue (GALT)
    What is the primary role of gut-associated lymphoid tissue (GALT) in the immune response?
    • A.To detect antigens in the gut and initiate immune responses
    • B.To increase the production of SCFAs in the gut
    • C.To produce antibodies against dietary proteins
    • D.To provide nutrients to gut microbiota
    Answer: A.To detect antigens in the gut and initiate immune responses
  244. 244
    Microbial Dysbiosis and Disease
    How does microbial dysbiosis in the gut contribute to immune-related diseases?
    • A.By increasing the diversity of the gut microbiome
    • B.By enhancing the growth of beneficial bacteria
    • C.By disrupting the balance between pro-inflammatory and anti-inflammatory responses
    • D.By decreasing the permeability of the intestinal barrier
    Answer: C.By disrupting the balance between pro-inflammatory and anti-inflammatory responses
  245. 245
    Impact of Probiotics on Gut Immunity
    How do probiotics influence gut immunity?
    • A.By inhibiting the production of SCFAs
    • B.By promoting the growth of beneficial bacteria and enhancing immune responses
    • C.By increasing the number of pathogenic bacteria
    • D.By reducing the production of IgA in the gut
    Answer: B.By promoting the growth of beneficial bacteria and enhancing immune responses
  246. 246
    Toll-Like Receptors (TLRs) in the Gut
    What role do Toll-like receptors (TLRs) on intestinal epithelial cells play in gut immunity?
    • A.They suppress immune responses to maintain tolerance
    • B.They prevent the absorption of dietary antigens
    • C.They directly produce antibodies against gut pathogens
    • D.They recognize microbial components and activate immune responses
    Answer: D.They recognize microbial components and activate immune responses
  247. 247
    Impact of Antibiotics on the Gut Microbiome
    How can long-term use of antibiotics negatively impact the immune system via the gut microbiome?
    • A.By promoting the secretion of protective mucins in the gut
    • B.By enhancing the growth of beneficial gut bacteria
    • C.By reducing microbial diversity and compromising immune regulation
    • D.By increasing the production of SCFAs
    Answer: C.By reducing microbial diversity and compromising immune regulation
  248. 248
    Bacteriophages and Immune Modulation
    How do bacteriophages in the gut microbiome influence the immune system?
    • A.By eliminating all bacteria from the gut
    • B.By increasing gut permeability and allowing pathogen invasion
    • C.By shaping the composition of bacterial populations, indirectly influencing immune responses
    • D.By directly competing with host immune cells
    Answer: C.By shaping the composition of bacterial populations, indirectly influencing immune responses
  249. 249
    IgA Production in the Gut
    What is the role of secretory IgA in the gut mucosal immunity?
    • A.It degrades dietary proteins for absorption
    • B.It facilitates the absorption of nutrients in the small intestine
    • C.It prevents bacterial adhesion to the gut epithelium
    • D.It enhances the inflammatory response to gut pathogens
    Answer: B.It facilitates the absorption of nutrients in the small intestine
  250. 250
    Gut Microbiome and Vaccine Responses
    How does the gut microbiome influence the efficacy of vaccines?
    • A.By modulating the immune system's response to antigens introduced by vaccines
    • B.By increasing gut permeability to improve antigen presentation
    • C.By directly producing antibodies against vaccine components
    • D.By eliminating memory T cells after vaccination
    Answer: A.By modulating the immune system's response to antigens introduced by vaccines
  251. 251
    Role of Natural Killer (NK) Cells in Tumor Immunity
    How do NK cells primarily recognize and eliminate tumor cells?
    • A.By detecting tumor-associated antibodies on the cell surface
    • B.By identifying tumor cells through complement activation
    • C.By recognizing the absence or downregulation of MHC class I molecules on tumor cells
    • D.By binding to the major histocompatibility complex (MHC) class I molecules
    Answer: C.By recognizing the absence or downregulation of MHC class I molecules on tumor cells
  252. 252
    Cytotoxic T Cells in Tumor Elimination
    What is the primary mechanism by which cytotoxic T cells (CTLs) eliminate tumor cells?
    • A.By secreting antibodies against tumor antigens
    • B.By triggering complement-mediated lysis of tumor cells
    • C.By releasing perforin and granzymes to induce apoptosis in target cells
    • D.By activating NK cells to kill the tumor cells
    Answer: C.By releasing perforin and granzymes to induce apoptosis in target cells
  253. 253
    Tumor Antigen Presentation
    How do dendritic cells (DCs) contribute to anti-tumor immunity?
    • A.By secreting cytokines that directly destroy tumor cells
    • B.By suppressing regulatory T cells that inhibit anti-tumor responses
    • C.By directly attacking tumor cells through phagocytosis
    • D.By presenting tumor antigens to T cells, initiating an adaptive immune response
    Answer: D.By presenting tumor antigens to T cells, initiating an adaptive immune response
  254. 254
    Tumor Immune Evasion via Checkpoint Molecules
    How do cancer cells utilize immune checkpoint molecules to evade immune detection?
    • A.By secreting inflammatory cytokines to distract immune cells
    • B.By expressing PD-L1, which binds to PD-1 on T cells to inhibit their activity
    • C.By upregulating MHC class II molecules
    • D.By inducing the production of antibodies that neutralize T cells
    Answer: B.By expressing PD-L1, which binds to PD-1 on T cells to inhibit their activity
  255. 255
    Tumor-Specific Antigens
    What role do tumor-specific antigens play in the immune response against cancer?
    • A.They enhance the formation of blood vessels around the tumor
    • B.They increase tumor cell replication rates
    • C.They prevent apoptosis in tumor cells
    • D.They are unique to cancer cells and serve as targets for T cell-mediated destruction
    Answer: D.They are unique to cancer cells and serve as targets for T cell-mediated destruction
  256. 256
    Role of Regulatory T Cells (Tregs) in Tumor Immunity
    How do regulatory T cells (Tregs) affect the immune system’s ability to eliminate tumors?
    • A.By suppressing anti-tumor immune responses, allowing tumor growth
    • B.By enhancing the cytotoxic activity of NK cells
    • C.By promoting dendritic cell maturation
    • D.By increasing the production of tumor-specific antibodies
    Answer: A.By suppressing anti-tumor immune responses, allowing tumor growth
  257. 257
    MHC Class I Downregulation in Tumor Cells
    What is the consequence of MHC class I downregulation in tumor cells?
    • A.It enhances recognition by cytotoxic T cells
    • B.It reduces recognition by cytotoxic T cells but increases susceptibility to NK cell-mediated killing
    • C.It protects the tumor from all immune cell recognition
    • D.It leads to increased tumor cell proliferation
    Answer: B.It reduces recognition by cytotoxic T cells but increases susceptibility to NK cell-mediated killing
  258. 258
    Immunoediting in Cancer Progression
    What is the concept of immunoediting in cancer development?
    • A.The immune system shapes tumor progression by selectively eliminating immunogenic tumor cells
    • B.Tumor cells edit immune cell function to become more aggressive
    • C.The immune system continuously attacks tumor cells, preventing their growth
    • D.Tumors evolve to evade the immune system by losing immunogenicity over time
    Answer: D.Tumors evolve to evade the immune system by losing immunogenicity over time
  259. 259
    Role of Tumor-Associated Macrophages (TAMs) in Cancer
    How do tumor-associated macrophages (TAMs) typically contribute to tumor growth and progression?
    • A.By directly phagocytosing tumor cells
    • B.By promoting angiogenesis, immune suppression, and tumor cell invasion
    • C.By stimulating T cells to attack the tumor
    • D.By secreting pro-inflammatory cytokines that destroy the tumor
    Answer: B.By promoting angiogenesis, immune suppression, and tumor cell invasion
  260. 260
    Checkpoint Inhibitors in Cancer Therapy
    How do immune checkpoint inhibitors, such as anti-PD-1 antibodies, enhance anti-tumor immunity?
    • A.By enhancing the proliferation of regulatory T cells
    • B.By directly targeting tumor antigens on the cell surface
    • C.By increasing the production of tumor-specific antibodies
    • D.By blocking the interaction between PD-1 on T cells and PD-L1 on tumor cells, restoring T cell activity
    Answer: D.By blocking the interaction between PD-1 on T cells and PD-L1 on tumor cells, restoring T cell activity
  261. 261
    Role of Major Histocompatibility Complex (MHC) in Transplant Rejection
    How does the difference in MHC between donor and recipient primarily influence transplant rejection?
    • A.By presenting donor antigens that are recognized as foreign by the recipient’s T cells
    • B.By reducing antibody production against the graft
    • C.By blocking cytokine release in the recipient
    • D.By enhancing T-cell tolerance to the graft
    Answer: A.By presenting donor antigens that are recognized as foreign by the recipient’s T cells
  262. 262
    Hyperacute Rejection Mechanism
    What is the primary mechanism involved in hyperacute transplant rejection?
    • A.Tolerance induced by immunosuppressive therapy
    • B.Gradual development of donor-specific antibodies over time
    • C.T-cell mediated lysis of donor cells
    • D.Preformed recipient antibodies binding to donor antigens, leading to complement activation
    Answer: D.Preformed recipient antibodies binding to donor antigens, leading to complement activation
  263. 263
    Direct Allorecognition in Transplant Rejection
    How does direct allorecognition contribute to transplant rejection?
    • A.Donor cells recognize and attack recipient tissues
    • B.Recipient T cells directly recognize donor MHC molecules on graft cells
    • C.Antibodies from the recipient bind directly to donor cells
    • D.Graft cells secrete cytokines that attract recipient neutrophils
    Answer: B.Recipient T cells directly recognize donor MHC molecules on graft cells
  264. 264
    Chronic Rejection Characteristics
    Which of the following best describes chronic transplant rejection?
    • A.It is a slow process characterized by fibrosis and loss of graft function over time
    • B.It occurs within minutes of transplantation
    • C.It involves acute inflammation and rapid destruction of the graft
    • D.It is mediated by preformed antibodies
    Answer: A.It is a slow process characterized by fibrosis and loss of graft function over time
  265. 265
    Role of Immunosuppressive Drugs
    How do immunosuppressive drugs like cyclosporine help in preventing transplant rejection?
    • A.By inhibiting the activation of T cells that recognize the graft
    • B.By promoting graft antigen presentation to recipient T cells
    • C.By enhancing the production of donor-specific antibodies
    • D.By increasing the activity of natural killer (NK) cells
    Answer: A.By inhibiting the activation of T cells that recognize the graft
  266. 266
    Mechanism of Graft-Versus-Host Disease (GVHD)
    What is the primary mechanism of graft-versus-host disease (GVHD) in bone marrow transplants?
    • A.Recipient antibodies neutralize donor antigens
    • B.T cells from the donor graft recognize and attack the recipient’s tissues
    • C.Recipient immune cells attack the donor graft
    • D.Donor immune cells attack the recipient’s tissues
    Answer: B.T cells from the donor graft recognize and attack the recipient’s tissues
  267. 267
    Indirect Allorecognition Pathway
    What is the role of the indirect allorecognition pathway in transplant rejection?
    • A.Donor T cells directly attack recipient tissues
    • B.Recipient neutrophils mediate immediate rejection
    • C.Recipient B cells directly recognize donor MHC molecules
    • D.Recipient dendritic cells process donor antigens and present them to recipient T cells
    Answer: D.Recipient dendritic cells process donor antigens and present them to recipient T cells
  268. 268
    Crossmatch Test and Transplant Compatibility
    What is the purpose of a crossmatch test before organ transplantation?
    • A.To test for infections in the donor organ
    • B.To detect preformed antibodies in the recipient that may cause hyperacute rejection
    • C.To match the blood types of the donor and recipient
    • D.To determine the genetic compatibility between donor and recipient
    Answer: B.To detect preformed antibodies in the recipient that may cause hyperacute rejection
  269. 269
    Antibody-Mediated Rejection (AMR)
    Which mechanism is involved in antibody-mediated rejection (AMR) of transplants?
    • A.Binding of recipient antibodies to donor endothelial cells, leading to complement activation
    • B.Activation of T cells specific to donor MHC
    • C.Destruction of the graft by recipient NK cells
    • D.Secretion of donor antigens into the bloodstream
    Answer: A.Binding of recipient antibodies to donor endothelial cells, leading to complement activation
  270. 270
    Regulatory T Cells (Tregs) in Transplant Tolerance
    How do regulatory T cells (Tregs) contribute to transplant tolerance?
    • A.By promoting the formation of fibrosis in the graft
    • B.By stimulating B cells to produce anti-graft antibodies
    • C.By suppressing the activation and proliferation of effector T cells that target the graft
    • D.By enhancing antigen presentation in the graft
    Answer: C.By suppressing the activation and proliferation of effector T cells that target the graft
  271. 271
    NK Cell Target Recognition
    How do natural killer (NK) cells differentiate between healthy cells and infected or cancerous cells?
    • A.By detecting antibodies bound to target cells via Fc receptors
    • B.By binding to CD4 receptors on target cells
    • C.By sensing the absence of MHC class I molecules on target cells
    • D.By recognizing pathogen-associated molecular patterns (PAMPs) on target cells
    Answer: C.By sensing the absence of MHC class I molecules on target cells
  272. 272
    Role of Perforin in NK Cell Function
    What is the function of perforin in the cytotoxic activity of NK cells?
    • A.To recruit other immune cells to the site of infection
    • B.To promote the expression of cytokines in the infected cell
    • C.To bind to antigens on the surface of infected cells
    • D.To create pores in the target cell membrane, allowing granzymes to enter
    Answer: D.To create pores in the target cell membrane, allowing granzymes to enter
  273. 273
    Activation of NK Cells by Cytokines
    Which cytokine plays a crucial role in the activation and enhancement of NK cell cytotoxicity?
    • A.Interleukin-2 (IL-2)
    • B.Tumor necrosis factor-alpha (TNF-α)
    • C.Transforming growth factor-beta (TGF-β)
    • D.Interleukin-10 (IL-10)
    Answer: A.Interleukin-2 (IL-2)
  274. 274
    NK Cell-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
    Which receptor on NK cells is involved in antibody-dependent cell-mediated cytotoxicity (ADCC)?
    • A.TLR4 receptor
    • B.MHC class II receptor
    • C.FcγRIII (CD16) receptor
    • D.CD28 receptor
    Answer: C.FcγRIII (CD16) receptor
  275. 275
    Inhibitory Receptors on NK Cells
    How do inhibitory receptors on NK cells contribute to self-tolerance?
    • A.By binding to MHC class I molecules on normal cells, preventing NK cell activation
    • B.By enhancing the production of cytokines that suppress immune responses
    • C.By promoting NK cell apoptosis in the presence of self-antigens
    • D.By releasing granzyme into healthy cells to trigger their death
    Answer: A.By binding to MHC class I molecules on normal cells, preventing NK cell activation
  276. 276
    Granzyme Function in NK Cell Activity
    What role do granzymes play in the function of NK cells?
    • A.They inhibit the proliferation of infected cells
    • B.They induce apoptosis in the target cell by cleaving cellular proteins
    • C.They enhance the expression of MHC class I molecules on infected cells
    • D.They increase the mobility of NK cells in tissues
    Answer: B.They induce apoptosis in the target cell by cleaving cellular proteins
  277. 277
    NK Cells and Interferon Production
    Which interferon produced by NK cells enhances their cytotoxic activity and stimulates other immune responses?
    • A.Interferon-lambda (IFN-λ)
    • B.Interferon-alpha (IFN-α)
    • C.Interferon-gamma (IFN-γ)
    • D.Interferon-beta (IFN-β)
    Answer: B.Interferon-alpha (IFN-α)
  278. 278
    Missing Self Hypothesis
    What is the central concept of the "missing self" hypothesis in NK cell function?
    • A.NK cells recognize and kill cells that lack MHC class I molecules
    • B.NK cells destroy cells expressing MHC class II molecules
    • C.NK cells are activated by the presence of stress ligands on target cells
    • D.NK cells kill cells that are deficient in self-MHC class I molecules
    Answer: D.NK cells kill cells that are deficient in self-MHC class I molecules
  279. 279
    Role of Activating Receptors on NK Cells
    What is the role of activating receptors on NK cells?
    • A.To increase MHC class I expression on target cells
    • B.To recognize self-antigens and inhibit cytotoxic activity
    • C.To bind stress-induced ligands on infected or transformed cells, promoting NK cell activation
    • D.To induce apoptosis in self-cells
    Answer: C.To bind stress-induced ligands on infected or transformed cells, promoting NK cell activation
  280. 280
    NK Cells in Tumor Immunosurveillance
    What role do NK cells play in tumor immunosurveillance?
    • A.They prevent angiogenesis in tumors
    • B.They release cytokines that cause tumor cell proliferation
    • C.They suppress T-cell activity within the tumor microenvironment
    • D.They recognize and destroy tumor cells that downregulate MHC class I molecules
    Answer: D.They recognize and destroy tumor cells that downregulate MHC class I molecules
  281. 281
    Mechanism of Autoimmune Diseases
    What is a primary mechanism leading to the development of autoimmune diseases?
    • A.Overproduction of cytokines
    • B.Increased number of regulatory T cells
    • C.Decreased production of immune cells
    • D.Failure of immune tolerance, resulting in the recognition of self-antigens as foreign
    Answer: D.Failure of immune tolerance, resulting in the recognition of self-antigens as foreign
  282. 282
    Role of Cytokine Storms in Disease
    How do cytokine storms contribute to disease progression in infections such as COVID-19?
    • A.By inhibiting viral replication
    • B.By directly attacking and neutralizing the pathogen
    • C.By causing excessive inflammation and tissue damage due to overactive immune signaling
    • D.By promoting healing and tissue regeneration
    Answer: C.By causing excessive inflammation and tissue damage due to overactive immune signaling
  283. 283
    Type I Hypersensitivity Reactions
    What is the initial immune response that leads to a Type I hypersensitivity reaction?
    • A.Activation of CD8+ T cells to destroy infected cells
    • B.Production of antibodies that target host tissues
    • C.Binding of allergens to IgE antibodies on mast cells, triggering degranulation
    • D.Activation of complement proteins by the antigen
    Answer: C.Binding of allergens to IgE antibodies on mast cells, triggering degranulation
  284. 284
    Role of T Regulatory Cells (Tregs) in Autoimmunity
    What is the function of T regulatory cells (Tregs) in preventing autoimmune diseases?
    • A.By promoting the differentiation of effector T cells
    • B.By suppressing immune responses that target self-antigens
    • C.By enhancing the production of pro-inflammatory cytokines
    • D.By increasing the production of autoantibodies
    Answer: B.By suppressing immune responses that target self-antigens
  285. 285
    Mechanism of Rheumatoid Arthritis
    Which immune mechanism is primarily responsible for the progression of rheumatoid arthritis?
    • A.Production of autoantibodies that target the synovium
    • B.T cell-mediated destruction of muscle tissue
    • C.Activation of the complement system leading to lysis of red blood cells
    • D.IgE-mediated allergic response to environmental antigens
    Answer: A.Production of autoantibodies that target the synovium
  286. 286
    Role of Immune Complexes in Type III Hypersensitivity
    How do immune complexes contribute to tissue damage in Type III hypersensitivity reactions?
    • A.By directly lysing host cells
    • B.By inhibiting the production of pro-inflammatory cytokines
    • C.By stimulating T cell proliferation
    • D.By depositing in tissues, leading to complement activation and inflammation
    Answer: D.By depositing in tissues, leading to complement activation and inflammation
  287. 287
    Molecular Mimicry and Autoimmune Diseases
    What role does molecular mimicry play in the development of autoimmune diseases?
    • A.By enhancing the immune response to pathogenic bacteria
    • B.By allowing immune cells to differentiate between self and non-self
    • C.By increasing the production of T regulatory cells
    • D.By causing cross-reactivity between foreign antigens and self-antigens, leading to an immune attack on self-tissues
    Answer: D.By causing cross-reactivity between foreign antigens and self-antigens, leading to an immune attack on self-tissues
  288. 288
    Mechanism of Immune Surveillance in Cancer
    How does immune surveillance prevent the progression of cancer?
    • A.By increasing the production of cancer-specific antibodies
    • B.By suppressing the immune system’s ability to recognize self-antigens
    • C.By stimulating angiogenesis to promote immune cell infiltration
    • D.By recognizing and eliminating cells that express abnormal proteins, such as tumor antigens
    Answer: D.By recognizing and eliminating cells that express abnormal proteins, such as tumor antigens
  289. 289
    Role of Complement System in Immune-Mediated Diseases
    How does the complement system contribute to the pathogenesis of immune-mediated diseases such as lupus?
    • A.By preventing the activation of the classical pathway
    • B.By enhancing antibody production against self-antigens
    • C.By forming membrane attack complexes (MACs) that damage host tissues
    • D.By promoting tolerance to foreign antigens
    Answer: C.By forming membrane attack complexes (MACs) that damage host tissues
  290. 290
    Mechanism of Graft Rejection
    What is the primary mechanism by which the immune system rejects transplanted organs?
    • A.By promoting angiogenesis in the transplanted tissue
    • B.By producing excessive amounts of immunoglobulins
    • C.By recognizing foreign major histocompatibility complex (MHC) molecules on donor cells and initiating a cytotoxic response
    • D.By increasing the number of regulatory T cells
    Answer: C.By recognizing foreign major histocompatibility complex (MHC) molecules on donor cells and initiating a cytotoxic response
  291. 291
    Role of HLA in Disease Susceptibility
    How do variations in human leukocyte antigen (HLA) genes contribute to disease susceptibility?
    • A.By reducing the overall number of T cells
    • B.By decreasing the body's ability to recognize self-antigens
    • C.By affecting antigen presentation to T cells, leading to differential immune responses
    • D.By altering the structure of cytokines
    Answer: C.By affecting antigen presentation to T cells, leading to differential immune responses
  292. 292
    Genetic Polymorphisms in Autoimmune Diseases
    Which type of genetic polymorphism is most commonly associated with autoimmune diseases?
    • A.Frameshift mutations in antibody genes
    • B.Structural variations in ribosomal RNA
    • C.Silent mutations in non-coding regions
    • D.Single nucleotide polymorphisms (SNPs) in immune regulatory genes
    Answer: D.Single nucleotide polymorphisms (SNPs) in immune regulatory genes
  293. 293
    Impact of Gene-Environment Interactions
    What role do gene-environment interactions play in disease susceptibility?
    • A.Environmental factors directly cause genetic mutations leading to disease
    • B.Gene-environment interactions prevent the development of autoimmune diseases
    • C.Genetic factors influence how the immune system responds to environmental triggers, increasing or decreasing disease risk
    • D.Genetic predispositions are unaffected by environmental influences
    Answer: C.Genetic factors influence how the immune system responds to environmental triggers, increasing or decreasing disease risk
  294. 294
    Epigenetic Modifications and Immune System Regulation
    How do epigenetic modifications contribute to immune system regulation?
    • A.By altering gene expression without changing the underlying DNA sequence
    • B.By causing permanent changes in DNA sequences
    • C.By enhancing the mutation rate in immune cells
    • D.By increasing the degradation of immune-related proteins
    Answer: A.By altering gene expression without changing the underlying DNA sequence
  295. 295
    MHC Polymorphism and Pathogen Resistance
    Why is high polymorphism in major histocompatibility complex (MHC) genes advantageous in populations?
    • A.It decreases the risk of autoimmunity
    • B.It prevents the development of allergies
    • C.It increases the ability to recognize a wide variety of pathogens
    • D.It reduces the likelihood of viral mutations
    Answer: C.It increases the ability to recognize a wide variety of pathogens
  296. 296
    Genetic Basis of Primary Immunodeficiency Diseases
    What is the primary cause of most primary immunodeficiency diseases (PIDs)?
    • A.Overactivation of immune responses
    • B.Mutations in genes that regulate immune system development or function
    • C.Somatic mutations in immune cells
    • D.Environmental factors like chronic infections
    Answer: B.Mutations in genes that regulate immune system development or function
  297. 297
    Genetic Contribution to Asthma Susceptibility
    Which genetic component is often linked to an increased risk of developing asthma?
    • A.Polymorphisms that affect lipid metabolism
    • B.Mutations in B-cell receptor genes
    • C.Mutations in cytokine genes that regulate inflammatory responses
    • D.Polymorphisms in genes involved in immune system regulation and airway hyperresponsiveness
    Answer: D.Polymorphisms in genes involved in immune system regulation and airway hyperresponsiveness
  298. 298
    Gene Editing and Disease Resistance
    How can gene editing techniques, such as CRISPR-Cas9, be used to reduce disease susceptibility?
    • A.By deleting non-coding regions of DNA
    • B.By directly altering immune response genes to confer resistance to specific pathogens
    • C.By removing polymorphisms linked to autoimmune diseases
    • D.By introducing protective mutations in genes associated with immune regulation
    Answer: D.By introducing protective mutations in genes associated with immune regulation
  299. 299
    Influence of Genetic Drift on Immune Variation
    How does genetic drift influence immune system variation in populations?
    • A.It increases immune system uniformity in large populations
    • B.It causes rapid increases in immune gene polymorphisms
    • C.It decreases the likelihood of pathogen resistance
    • D.It can lead to the loss or fixation of immune-related alleles in small populations
    Answer: D.It can lead to the loss or fixation of immune-related alleles in small populations
  300. 300
    Impact of Copy Number Variations (CNVs) in Immunogenetics
    What is the significance of copy number variations (CNVs) in the context of immunogenetics?
    • A.CNVs prevent the expression of HLA genes
    • B.CNVs are unrelated to immune function
    • C.CNVs can lead to variations in immune gene dosage, affecting immune responses and susceptibility to diseases
    • D.CNVs decrease the diversity of immune cell receptors
    Answer: C.CNVs can lead to variations in immune gene dosage, affecting immune responses and susceptibility to diseases

Reset your progress?

This clears your answers for this practice bank. Your score will start over.

Other topic areas